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Abstract	  	  
Background:	  P-­‐type	  ATPases	  are	  ubiquitous	  ion	  and	  lipid	  pumps	  found	  in	  cellular	  membranes.	  P5A-­‐ATPases	   constitute	   a	   poorly	   characterized	   subfamily	   of	   P-­‐type	   ATPases	   present	   in	   all	  eukaryotic	  organisms	  but	  for	  which	  a	  transported	  substrate	  remains	  to	  be	  identified.	  	  
Scope	   of	   review:	   This	   review	   aims	   to	   discuss	   the	   available	   evidence	   which	   could	   lead	   to	  identification	  of	  possible	  substrates	  of	  P5A-­‐ATPases.	  
Major	  conclusions:	  The	  complex	  phenotypes	  resulting	  from	  the	  loss	  of	  P5A-­‐ATPases	  in	  model	  organisms	  can	  be	  explained	  by	  a	  role	  of	  the	  P5A-­‐ATPase	  in	  the	  endoplasmic	  reticulum	  (ER),	  where	  loss	  of	  function	  leads	  to	  broad	  and	  unspecific	  phenotypes	  related	  to	  the	  impairment	  of	  basic	   ER	   functions	   such	   as	   protein	   folding	   and	   processing.	   Genetic	   interactions	   in	  
Saccharomyces	  cerevisiae	  point	  to	  a	  role	  of	  the	  endogenous	  P5A-­‐ATPase	  Spf1p	  in	  separation	  of	  charges	   in	  the	  ER,	   in	  sterol	  metabolism,	  and	   in	   insertion	  of	   tail-­‐anchored	  proteins	   in	  the	  ER	  membrane.	  A	  role	   for	  P5A-­‐ATPases	   in	  vesicle	   formation	  would	  explain	  why	  sterol	   transport	  and	  distribution	  are	  affected	   in	  knock	  out	   cells,	  which	   in	   turn	  has	  a	  negative	   impact	  on	   the	  spontaneous	  insertion	  of	  tail-­‐anchored	  proteins.	  It	  would	  also	  explain	  why	  secretory	  proteins	  destined	   for	   the	   Golgi	   and	   the	   cell	   wall	   have	   difficulties	   in	   reaching	   their	   final	   destination.	  Cations	  and	  phospholipids	  could	  both	  be	  transported	  substrates	  of	  P5A-­‐ATPases	  and	  as	  each	  carry	  charges,	  transport	  of	  either	  might	  explain	  why	  a	  charge	  difference	  arises	  across	  the	  ER	  membrane	  
General	   significance:	   Identification	   of	   the	   substrate	   of	   P5A-­‐ATPases	   would	   throw	   light	   an	  important	  general	  process	  in	  the	  ER	  that	  is	  still	  not	  fully	  understood.	  	   	  
	   3	  
1.	  Background	  	  The	   P-­‐type	   ATPase	   family	   constitutes	   a	   large	   class	   of	   membrane	   proteins	   which	   catalyze	  active	   transport	   of	   ions	   and	   lipids	   across	   biological	  membranes.	   The	   family	   can	   be	   divided	  phylogenetically	   into	   five	   distinct	   subfamilies	   (P1–P5),	   each	   of	  which	   can	   again	   be	   divided	  into	   additional	   subgroups	   (A,	   B,	   etc.)	   [1,	   2].	   The	   phylogenetic	   division	   correlates	  well	  with	  differences	   in	   the	  preferred	   transport	   substrates.	  P1-­‐P3	  ATPases	  are	  well-­‐characterized	   ion	  pumps:	  P1A	  are	  part	  of	  bacterial	  K+	  transport	  systems,	  P1B	  are	  heavy	  metal	  pumps,	  P2A	  and	  P2B	  are	  Ca2+	  pumps,	  P2C	  Na+/K+	  pumps	  in	  animals,	  P2D	  are	  Na+	  pumps	  in	  fungi	  and	  mosses,	  and	  P3A	  are	  plasma	  membrane	  H+	  pumps	  found	  in	  fungi	  and	  plants.	  In	  contrast,	  P4	  ATPases	  participate	  in	  lipid	  flipping	  across	  membranes.	  	  	  The	   last	   subfamily	   in	   the	   superfamily,	   the	   P5-­‐ATPases,	   has	   remained	   uncharacterized	  with	  respect	  to	  substrate	  transport	  and	  thus	  so	  far	  has	  no	  assigned	  specificity.	  P5-­‐ATPases	  form	  a	  monophyletic	   group	   and	   the	   same	   phylogenetic	   origin	   as	   lipid	   flipping	   P4-­‐ATPases.	   Their	  transport	   function,	   if	   they	  have	  one,	   remains	  elusive.	  No	  homologues	  have	  been	  detected	   in	  bacterial	   genomes	   even	   though	   P5-­‐ATPases	   are	   found	   in	   every	   single	   eukaryotic	   genome	  analysed	  so	  far	  [3,	  4].	  Their	  ubiquitous	  presence	  in	  eukaryotic	  cells	  indicates	  that	  they	  play	  a	  fundamental	  yet	  undescribed	  role	  that	  is	  not	  required	  in	  prokaryotes	  but	  emerged	  in	  cells	  at	  the	  branching	  point	  between	  prokaryotes	  and	  eukaryotes.	  	  	  P5-­‐ATPases	   can	   be	   divided	   into	   two	   subclasses,	   P5A	   and	   P5B,	   based	   on	   conservation	   of	  residues	   in	   the	   putative	   transport	   binding	   sites	   [3]	   and	   on	   their	   predicted	   transmembrane	  topology	  [5].	  The	  P5A	  subgroup	  includes	  a	  negatively	  charged	  motif	  in	  the	  putative	  transport	  binding	   site	   in	   M4	   (PP(D/E)LPxE)	   and	   has	   two	   extra	   transmembrane	   spanning	   helices	  predicted	   in	   the	   N-­‐terminal	   region	   (Ma	   and	   Mb)(Figure	   1).	   On	   the	   other	   hand	   the	   P5B	  subgroup	  shows	  no	  conservation	  of	  charged	  residues	  in	  the	  M4	  motif	  (PP(A/V)LPAx)	  and	  has	  only	   one	   extra	   predicted	   transmembrane	   helix	   in	   the	   N-­‐terminal	   region	   (Ma).	   The	   extra	  transmembrane	  helices	   predicted	   in	  P5A-­‐	   and	  P5B-­‐ATPases	   show	   low	   conservation	   and	  no	  homology	   to	  other	  P-­‐type	  ATPase	  membrane	  segments.	  Whereas	  P5A-­‐ATPases	  are	   found	   in	  all	   eukaryotic	   genomes,	   P5B-­‐ATPases	   have	   been	   lost	   in	   some	   lineages	   of	   multicellular	  eukaryotes	  including	  land	  plants	  [3]	  and	  will	  not	  be	  the	  focus	  of	  this	  review.	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  An	  accumulating	  number	  of	  localization	  studies	  highlight	  that	  P5A-­‐ATPases	  mainly	  associate	  with	  the	  endoplasmic	  reticulum	  (ER),	  a	  hallmark	  of	  eukaryotic	  cells.	  The	  single	  P5A-­‐ATPase	  in	  
Saccharomyces	  cerevisiae,	  Spf1p,	  localizes	  in	  the	  membrane	  of	  the	  ER	  [6,	  7]	  and	  in	  the	  cis-­‐Golgi	  compartment	   [8].	   Likewise	   the	  Spf1p	  homologues	   in	  Schizosaccharomyces	  pombe	   [9]	   and	   in	  the	   higher	   multicellular	   plant	   Arabidopsis	   thaliana	   [10]	   localize	   to	   the	   ER	   membrane.	   In	  vertebrate	   genomes,	   P5A-­‐ATPases	   are	   encoded	   for	   by	   a	   single	   gene	   (entitled	   Atp13a1	   and	  ATP13A1	  in	  the	  mouse	  and	  human	  genomes,	  respectively).	  	  2.	  Scope	  of	  review	  	  Despite	   intense	   investigation	   and	   a	   sharp	   increase	   in	   genetic	   data	   from	   high	   throughput	  studies	  we	   still	   do	   not	   understand	   the	  molecular	   function	   of	   any	   P5A-­‐ATPase.	   For	   the	   best	  studied	   P5A-­‐ATPase,	   Spf1p,	   an	   immense	   amount	   of	   information	   has	   accumulated	   in	   recent	  years	  as	  the	  result	  mainly	  of	  genetic	  high	  throughput	  studies.	  	  However,	  we	  are	  still	  far	  from	  understanding	   the	   function	   of	   Spf1p.	   One	   reason	   is	   that	   the	   phenotype	   of	   spf1	   mutants	   is	  pleiotropic,	  that	  is,	  a	  mutation	  in	  the	  SPF1	  gene	  results	  in	  multiple	  phenotypic	  traits	  most	  of	  which	  seem	  unrelated.	   In	  this	  review,	  and	  following	  a	  general	   introduction	  to	  the	  structure-­‐function	  relationship	  of	  P5A-­‐ATPases,	  the	  accumulated	  genetic	  data	  on	  SPF1	  will	  be	  reviewed	  with	  the	  goal	  to	  identify	  correlations	  that	  have	  not	  been	  observed	  before	  and	  that	  could	  throw	  light	  on	  the	  molecular	  function	  of	  P5A-­‐ATPases.	  	  3.	  Structure-­‐function	  relationship	  of	  P5A-­‐ATPases	  	  All	  P-­‐type	  ATPases	  function	  by	  a	  similar	  reaction	  mechanism	  in	  which	  an	  invariant	  aspartate	  residue	   is	   phosphorylated	   during	   the	   catalytic	   cycle.	   A	   nucleotide	   binding	   domain	   (the	   N-­‐domain)	   binds	   ATP	   and	   serves	   as	   a	   built-­‐in	   protein	   kinase,	   which	   phosphorylates	   the	   P-­‐domain.	   The	   A-­‐domain	   is	   an	   intrinsic	   protein	   phosphatase,	   which	   dephosphorylates	   the	   P-­‐domain	   once	   during	   each	   catalytic	   cycle.	   The	   process	   is	   tightly	   coupled	   to	   formation	   and	  deformation	  of	  high	  affinity	  binding	  sites	  in	  the	  transport	  domain	  by	  an	  allosteric	  mechanism	  [11].	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3.1	  Overall	  fold	  and	  signature	  sequences	  	  P5A-­‐ATPases	  have	  all	  the	  characteristic	  key	  signatures	  of	  a	  P-­‐type	  ATPase	  indicating	  that	  the	  overall	   P-­‐type	   domain	   architecture	   is	   conserved	   (Figure	   1).	   Sequence	   motifs	   shared	   with	  other	   P-­‐type	   pumps,	   such	   as	   the	   nucleotide	   interaction	   site	   (KGAPE),	   the	   lysine	   of	   which	  interacts	  with	  the	  adenine	  ring	  of	  ATP	  [12],	  the	  phosphorylation	  site	  (DKTGL),	  which	  becomes	  phosphorylated	  on	   the	   aspartate	   residue	  during	   catalysis,	   and	   the	   site	   (TGE)	   in	   the	  built-­‐in	  protein	  phosphatase,	  which	   is	   required	   for	  catalytic	  cleavage	  of	   the	  phosphoenzyme,	  are	  all	  completely	   conserved	   in	   P5A-­‐ATPases.	   This	   suggests	   a	   common	  mechanism	   between	   these	  putative	  pumps	  and	  other	  P-­‐type	  ATPases.	  	  3.2	  Transport	  binding	  sites	  	  In	   P-­‐type	   ATPase,	   the	   ligand	   to	   be	   transported	   is	   coordinated	   by	   functional	   groups	   in	   the	  membrane-­‐embedded	   M-­‐domain	   [11].	   In	   particular,	   residues	   in	   transmembrane	   segments	  M4,	  M5,	  and	  M6	  are	  involved	  in	  ligand	  binding	  whereas	  other	  residues	  in	  M1,	  M2,	  and	  M3	  are	  part	  of	  the	  ligand	  translocation	  pathway.	  P5-­‐ATPases	  can	  be	  identified	  by	  a	  signature	  PPxxP	  motif	   found	   in	   transmembrane	   segment	   M4,	   which	   has	   an	   additional	   proline	   compared	   to	  Na+/K+,	  Ca2+	  and	  H+	  ATPases	  that	  have	  a	  conserved	  Pxxx(P/L)	  motif	  at	  the	  same	  site	  [3].	  The	  first	  proline	   in	  this	  motif	   induces	  unwinding	  of	  transmembrane	  segment	  M4	  in	  all	  solved	  P-­‐type	  ATPase	  structures.	  This	  twist	  in	  turn	  exposes	  backbone	  carbonyl	  oxygens	  that	  are	  used	  to	  coordinate	  a	  transported	  cation.	  P5A-­‐ATPase	  sequences	  contain	  a	  PP(E/D)xPx(E/D)	  motif	  with	   two	   conserved	   negatively	   charged	   residues	   whereas	   P5B-­‐ATPase	   sequences	   are	  characterized	  by	  a	  PP(A/V)xP(A/V)x	  motif	  with	   two	  conserved	  hydrophobic	  residues	  at	   the	  same	  position.	  The	  presence	  and	  absence	  of	  two	  negative	  charges	  at	  this	  position	  should	  have	  a	   strong	   impact	   on	   the	   electrical	   field	   in	   the	   unwound	   helix	   region,	   which	   is	   likely	   to	  differentially	  influence	  the	  substrate	  specificity	  of	  the	  two	  subgroups.	  The	  two	  subclasses	  thus	  most	  likely	  transport	  different	  substrates	  although	  this	  has	  yet	  to	  be	  proven.	  	  	  The	  ion	  translocation	  pathways	  so	  far	  established	  are	  centered	  on	  M1–M6	  segments	  of	  the	  M-­‐domain.	   Nevertheless	   several	   features	   of	   the	   core	   show	   large	   sequence	   variations	   among	  subclasses,	   such	   as	   the	   linkers	   of	  M4	   and	  M5	   to	   the	   P-­‐domain,	   suggesting	   subclass	   specific	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modulation	  of	   the	   core	  activity.	   In	   this	   regard	   it	   is	   interesting	   that	  an	   insert	  of	   varying	   size	  seems	   to	   be	   present	   in	   the	   P5A	  ATPase	   primary	   sequence,	  which	  would	   separate	   the	  Mg2+	  binding	   site	   close	   to	   the	   phosphorylated	   aspartate	   and	   the	   extended	   M5	   helix	   involved	   in	  allosteric	  communication	  between	  the	  phosphorylation	  site	  in	  the	  P-­‐domain	  and	  the	  substrate	  binding	  site	  in	  the	  M-­‐domain	  [5].	  	  	  3.3	  P5A-­‐ATPases	  contain	  an	  extended	  N-­‐terminal	  region	  	  	  The	   extra	   N-­‐terminal	   membrane	   segments	   Ma	   and	  Mb	   are	   overall	   poorly	   conserved	   in	   P5	  ATPases	  and	  display	  no	  obvious	  candidate	  residues	  for	  ion	  coordination	  [5].	  Although	  there	  is	  no	  evidence	   that	   they	  are	  directly	   involved	   in	   establishing	   a	  high-­‐affinity	   intramembranous	  transport	  binding	  site,	  an	  interesting	  topological	  comparison	  can	  be	  made	  with	  respect	  to	  the	  additional	  membrane-­‐spanning	   segments	  Ma	  and	  Mb	   located	   in	   the	  N-­‐terminus	  of	   the	  P1B-­‐type	   ATPases.	   In	   the	   structure	   of	   the	   CopA	   Cu+	   transporter,	   the	   N-­‐terminal	   segments	   are	  structurally	   important	   to	   establish	   a	   substrate	   delivery	   site	   [13,	   14].	   The	   N-­‐terminus	  composes	  a	  docking	  platform	  for	  the	  binding	  of	  a	  Cu+	  chaperone,	  which	  delivers	  its	  Cu+	  to	  the	  pump.	  It	  remains	  to	  be	  verified	  whether	  Cu+	  is	  directly	  delivered	  to	  the	  Cu+	  transport	  binding	  sites,	  or	  whether	  the	  Cu+	  ion	  transiently	  binds	  to	  the	  N-­‐terminal	  heavy	  metal	  binding	  domains.	  In	  the	  CopA	  structure,	  Ma	  forms	  a	  continuous	  helix	  through	  the	  membrane	  while	  MB	  consists	  of	  two	  segmented	  helices	  -­‐	  a	  membrane	  spanning	  helix	  (Mb)	  and	  a	  perpendicular	  amphipathic	  helix	  nested	  at	  the	  cytoplasmic	  interface	  (Mb’),	  the	  two	  being	  separated	  by	  a	  highly	  conserved	  glycine.	  In	  comparison,	  P5A-­‐ATPases	  show	  high	  conservation	  of	  a	  proline	  (Pro-­‐31	  in	  Spf1p)	  at	  a	  similar	  position	   in	  the	  first	  membrane	  spanning	  helix	  (Mb)	  [5]	  making	   it	  possible	  that	  the	  extended	   N-­‐terminal	   region	   follows	   a	   similar	   fold	   as	   in	   the	   P1B	   heavy	   metal	   transporting	  ATPases.	   It	   thus	   seems	   plausible	   that	   the	   N-­‐terminal	   region	   might	   represent	   a	   docking	  platform	  for	  substrate	  delivery,	  either	  by	  direct	  binding	  of	  the	  substrate	  to	  the	  N-­‐terminus	  or	  by	  interaction	  with	  a	  protein	  partner.	  	  Another	  possibility	  is	  that	  the	  N-­‐terminal	  region	  functions	  as	  a	  regulator	  of	  catalytic	  function.	  In	  the	  plasma	  membrane	  Ca2+	  ATPase,	  the	  plasma	  membrane	  H+	  ATPase	  and	  the	  Drs2p	  lipid	  flippase,	   transport	   activity	   is	   auto-­‐inhibited	   by	   N-­‐	   or	   C-­‐terminal	   sequences,	   which	   can	   be	  relieved	  by	  various	  stimuli.	  In	  the	  P1B-­‐ATPases	  an	  extended	  cytoplasmic	  tail	  in	  the	  N-­‐terminal	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region,	  loaded	  with	  various	  numbers	  of	  heavy	  metal	  binding	  sites,	  functions	  as	  a	  regulator	  of	  transport	  function	  by	  acting	  either	  on	  catalytic	  turnover	  or	  the	  transport	  coupling	  ratio	  in	  the	  pump	   [15-­‐17].	   The	   bend	   MB	   segment	   in	   P1B-­‐ATPases	   is	   thus	   likely	   to	   be	   involved	   in	  controlling	  the	  access	  of	  chaperones	  to	  the	  ion	  entry	  site	  of	  the	  M-­‐domain	  which	  in	  turn	  can	  be	  auto-­‐regulated	  by	  blockage	  of	  the	  heavy-­‐metal	  binding	  domain.	  The	  human	  copper	  ATPase	  involved	   in	  Wilson	  Disease	  (ATP7B)	   is	   for	   instance	  phosphorylated	   in	   the	  N-­‐terminal	  heavy	  metal-­‐binding	   region	   where	   phosphorylation	   affects	   the	   interaction	   of	   the	   heavy	   metal-­‐binding	  region	  and	  headpiece	  domains	  with	  strong	  influence	  on	  the	  catalytic	  properties	  of	  the	  enzyme	   [18].	   	   So	   in	   other	   P-­‐type	   ATPases	   long	   N-­‐	   or	   C-­‐terminal	   stretches	   regulate	   pump	  function.	   A	   few	   (mostly	   fungal)	  members	   of	   the	   P5-­‐ATPases	   display	   an	   extended	   sequence	  stretch	   in	   either	   the	  N-­‐terminal	   region	   (e.g.	   the	   yeast	   orthologue	  Ypk9p	   is	   equipped	  with	   a	  predicted	   cytoplasmic	   N-­‐terminal	   tail	   of	   293	   amino	   acid	   residues).	   However,	   the	   general	  picture	  is	  that	  P5-­‐ATPases	  lack	  large	  cytoplasmic	  tails	  positioned	  before	  or	  after	  the	  N-­‐	  or	  C-­‐terminal	  membrane	  segments,	  respectively.	  	  	  4.	  Genetics	  of	  P5A-­‐ATPase	  function	  in	  a	  model	  organism	  	  P5A-­‐ATPases	  appear	  to	  be	  exclusively	  localized	  to	  the	  ER.	  Loss	  of	  P5A-­‐ATPase	  gene	  function	  in	  both	  plant	  and	  yeast	  has	  been	  established	  to	  lead	  to	  broad	  unspecific	  phenotypes	  related	  to	  an	   inability	   to	   maintain	   basic	   secretory	   pathway	   functions.	   In	   order	   to	   understand	   their	  function	   in	   the	   cell	  we	  have	   chosen	   to	   focus	  on	   the	  available	  evidence	   linked	   to	   function	  of	  P5A-­‐ATPases	   in	   a	   simple	   eukaryotic	   model	   organism,	   the	   yeast	   S.	   cerevisiae.	  As	   has	   been	  demonstrated	  in	  an	  ample	  number	  of	  occasions,	  knowledge	  obtained	  in	  this	  system	  is	  likely	  to	  be	  broadly	  applicable	  to	  other	  eukaryotic	  systems	  [19,	  20].	  	  4.1	  Spf1p	  of	  Saccharomyces	  cerevisiae	  as	  a	  model	  P5A-­‐ATPase	  	  
SPF1,	  the	  single	  gene	  in	  S.	  cerevisiae	  encoding	  a	  P5A-­‐ATPase,	  was	  first	  identified	  in	  a	  screen	  of	  mutagenized	  cells	  that	  showed	  resistance	  to	  the	  killer	  toxin	  SMKT	  secreted	  by	  Pichia	  farinosa,	  hence	  the	  name	  Sensitivity	  to	  Pichia	  farinosa	  [21].	  In	  spf1	  mutant	  cells,	  the	  toxin	  is	  retained	  at	  the	  cell	  wall	  and	  does	  not	  get	  internalized	  hereby	  representing	  a	  molecular	  mechanism	  for	  the	  resistance	   of	   mutant	   cells	   [22,	   23].	   However,	   as	   the	   Spf1p	   protein	   was	   localized	   to	   the	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endoplasmic	   reticulum	   (ER)	   and	   putatively	   encoded	   an	   ion	   pump,	   a	   link	   between	   protein	  function	  and	  the	  cellular	  impact	  of	  its	  activity	  could	  not	  be	  identified.	  	  According	  to	  the	  Saccharomyces	  cerevisiae	  Genome	  Database	  (http://yeastgenome.org),	  at	  the	  time	   of	   the	  writing	   of	   this	   review,	  more	   than	   500	   experiments	   have	   now	   reported	   genetic	  interactions	  that	   involve	  SPF1	  or	   its	  encoded	  protein,	  and	  the	   list	  comprises	  309	  genes.	  The	  vast	  majority	  of	  these	  genetic	  interactions	  are	  negative	  and	  17	  are	  synthetic	  lethal.	  In	  genetics,	  two	   genes	   interact	   negatively	   if	   the	   combination	   of	  mutations	   in	   both	   produces	   a	   stronger	  effect	   than	   expected	   from	   the	   phenotype	   of	   two	   single	  mutants	   and,	   in	   the	  worst	   case,	   the	  organism	  does	  not	  survive	  the	  combined	  effect	  and	  the	  effect	  is	  said	  to	  be	  synthetic	  lethal.	  The	  interactors	  fall	   in	  separate	  clusters	  (Figure	  2A)	  and	  vary	  tremendously	  both	  with	  respect	  to	  cellular	  location	  (Figure	  2B)	  and	  predicted	  function	  (Figure	  2C).	  Figure	  3	  provides	  a	  summary	  of	   the	   function	   and	   cellular	   localization	   of	   major	   proteins	   that	   exert	   activities	   which	   are	  related	  to	  Spf1p.	  Supplemental	  Table	  1	  integrates	  genetic	  and	  physical	  interactions	  from	  high-­‐	  and	   low	   throughput	   studies	   in	   yeast	   available	   at	   BioGrid	   (http://thebiogrid.org).	  Furthermore,	  the	  data	  from	  five	  high	  throughput	  genetic	  interaction	  yeast	  studies	  have	  been	  included	  and	  sorted	  by	  colony	  size	  to	  show	  the	  relative	  intensities	  of	  the	  genetic	  interactions	  within	  each	  study.	  	  4.2.	  Spf1p	  and	  the	  unfolded	  protein	  response	  	  
	  What	   remains	   evident	   from	   the	   information	   gathered	   so	   far	   is	   that	   Spf1p	   is	   tremendously	  important	  for	  homeostasis	  of	  the	  ER.	  In	  the	  ER,	  newly	  synthesized	  proteins	  are	  folded	  and	  are	  subsequently	  processed	  by	  post-­‐translational	  modifications	  that	  can	  involve	  glycosylation	  or	  addition	   of	   GPI-­‐anchors	   followed	   by	   their	   transport	   to	   the	   Golgi	   apparatus	   where	   further	  modifications	   may	   occur	   [23-­‐26].	   Inhibition	   of	   any	   of	   these	   processes	   in	   this	   complicated	  machinery	   may	   affect	   ER	   homeostasis	   and,	   as	   a	   consequence,	   result	   in	   accumulation	   of	  unfolded	  proteins	  in	  the	  ER.	  	  	  Strikingly,	   in	  a	  screen	  among	  deletions	  of	  non-­‐essential	  genes	   in	  S.	  cerevisiae	   (around	  4,500	  genes),	   the	   knockout	   strain	   that	   exhibited	   the	   third	   strongest	   unfolded	   protein	   response	  (UPR)	  was	  the	  spf1	  mutant	  [27].	  This	  connection	  is	  conserved	  in	  other	  organisms	  as	  well,	  as	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induced	   activation	   of	   the	   unfolded	   protein	   response	   in	   Aspergillus	   nidulans	   results	   in	  increased	   expression	   of	   the	   SPF1	   ortholog,	   AN3146.2	   [28].	   In	   multicellular	   organisms	   like	  plants,	   disruption	   of	   the	   single	   P5A-­‐ATPase	   gene,	   AtP5A1/MIA/PDR2,	   also	   correlates	   with	  sensitizing	  of	   a	   subset	   of	  ER	  quality	   control	   responses	   [10,	   29].	   The	  mutant	   also	  displays	   a	  changed	   expression	   pattern	   of	   genes	   belonging	   to	   functional	   groups	   of	   protein	   secretion,	  protein	  folding	  and	  solute	  transport	  and	  has	  an	  altered	  homeostasis	  of	  cations	  [10].	  	  Unfolded	   proteins	   are	   recognized	   in	   the	   ER	   by	   the	   membrane-­‐embedded	   protein	   Inositol-­‐requiring	   enzyme1	   (Ire1p)	   [30-­‐32],	   which	   on	   the	   luminal	   side	   of	   the	   ER	  membrane	   has	   a	  receptor-­‐domain	  that	  senses	  unfolded	  polypeptides.	  On	  the	  cytoplasmic	  side	  of	  the	  ER,	  Ire1p	  has	  a	  domain	  with	  RNase	  activity,	  which	  specifically	  recognizes	  the	  mRNA	  of	  the	  transcription	  factor	  Hac1p.	  The	  HAC1	  gene	  is	  one	  of	  the	  few	  yeast	  genes	  with	  an	  intron.	  Following	  activation	  of	  Ire1p,	  the	  RNase	  activity	  of	  Ire1p	  splices	  the	  mRNA	  of	  HAC1,	  and	  -­‐	  following	  removal	  of	  the	  intron	  -­‐	  Hac1	  protein	  is	  synthesized	  [33,	  34].	  The	  Hac1p	  transcription	  factor	  migrates	  to	  the	  nucleus	  where	  it	  coordinates	  the	  expression	  of	  genes,	  such	  as	  chaperones,	  that	  are	  involved	  in	  the	  unfolded	  proteins	  response	  (UPR)	  [32,	  35].	  	  	  The	  mutant	  yeast	  strain	  per9	  was	  isolated	  in	  a	  screen	  for	  mutants	  that	  show	  a	  synthetic	  lethal	  interaction	  with	  IRE1	  [36].	  The	  PER9	  gene	  was	  cloned	  and	  found	  to	  be	  identical	  to	  SPF1	  [7].	  In	  a	  parallel	  approach,	  a	  mutation	  in	  SPF1	  was	  found	  to	  be	  synthetic	  lethal	  in	  combination	  with	  a	  knockout	  in	  HAC1	  [6].	  The	  conclusion	  is	  that	  a	  mutation	  in	  SPF1	  causes	  such	  disturbance	  of	  ER	  homeostasis	  that,	  without	  Ire1p	  or	  Hac1p	  to	  initiate	  repair	  of	  the	  damage,	  the	  effect	  is	  lethal.	  	  	  From	  an	  overview	  of	  all	  deletions	  of	  non-­‐essential	  genes,	  which	  trigger	  the	  unfolded	  protein	  response,	   it	   is	   clear	   that	   defects	   in	   the	  N-­‐linked	   glycosylation	   pathway	   and	   ER-­‐associated	  degradation	  cause	  massive	  induction	  of	  UPR	  [27].	  Similarly	  high	  inductions,	  however,	  are	  also	  found	  following	  deletion	  of	  genes	  involved	  in	  other	  processes	  such	  as	  membrane-­‐insertion	  of	  tail-­‐anchored	   proteins,	   lipid	   biosynthesis,	   glycophosphatidylinositol	   anchor	   synthesis,	   O-­‐mannosylation,	  vesicle	  trafficking	  and	  ion	  homeostasis.	  Below	  we	  discuss	  the	  vital	  roles	  Spf1p	  carries	   out	   in	   membrane	   protein	   insertion,	   sterol	   biosynthesis,	   vesicle	   trafficking,	   protein	  glycosylation,	   GPI	   anchor	   synthesis,	   and	   cell	   wall	   formation.	   Lack	   of	   Spf1p	   in	   any	   of	   these	  processes	  induces	  the	  UPR	  system	  to	  re-­‐establish	  ER	  homeostasis.	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  4.3.	  Spf1p	  and	  insertion	  of	  membrane	  proteins	  into	  the	  ER	  membrane	  
	  Membrane	   proteins	   are	   inserted	   into	   the	   ER	   membrane	   following	   their	   synthesis	   and	  subsequently	   may	   travel	   to	   other	   parts	   of	   the	   cell	   via	   the	   secretory	   pathway.	   Single-­‐pass	  transmembrane	  proteins	  have	  only	  a	  single	  transmembrane	  segment	  that	  anchors	  them	  in	  the	  ER	  membrane.	  Multi-­‐pass	   transmembrane	   proteins	   have	   several	   transmembrane	   segments	  that	  following	  their	  synthesis	  have	  to	  be	  oriented	  correctly	  within	  the	  membrane.	  Membrane	  proteins	  without	  transmembrane	  segments	  can	  be	  anchored	  in	  the	  ER	  membrane	  by	  covalent	  attachment	   to	  a	  glycophosphatidylinositol	   (GPI)	  anchor	   that	   is	  embedded	   in	   the	  membrane.	  As	  will	  be	  evident	  from	  the	  following,	  Spf1p	  appears	  to	  be	  important	  for	  most	  of	  the	  processes	  related	  to	  insertion	  of	  membrane	  proteins	  in	  the	  ER	  membrane.	  
	  4.3.1.	  Spf1	  and	  the	  topology	  of	  insertion	  of	  integral	  membrane	  proteins	  	  All	  integral	  membrane	  proteins	  of	  the	  plasma	  membrane	  and	  most	  of	  the	  membrane	  proteins	  in	   intracellular	   membranes	   are	   first	   integrated	   in	   the	   ER	   before	   they	   travel	   to	   other	  destinations	  in	  the	  cells	  [37].	  The	  classical	  co-­‐translational	  pathway	  involves	  recognition	  of	  a	  hydrophobic	   segment	   by	   the	   signal	   recognition	   particle	   [38]	   followed	   by	   transfer	   to	   the	  translocon,	   or	   Sec61	   complex,	  which	   inserts	   the	   hydrophobic	   sequence	   stretch	   into	   the	   ER	  membrane	   [37].	   The	   major	   signals	   determining	   the	   direction	   of	   insertion	   of	   a	   newly	  synthesized	  transmembrane	  segment	  in	  the	  membrane	  is:	  i)	  the	  charge	  difference	  across	  the	  membrane;	   and	   ii)	   its	   total	   hydrophobicity	   [39-­‐42].	   In	   prokaryotes,	   the	   electric	   field	   that	  drives	   insertion	  of	  membrane	  proteins	  the	  cell	  membrane	  is	  the	  result	  of	  a	  proton	  gradient,	  positive	   on	   the	   outside,	   negative	   at	   the	   cytoplasmic	   side	   of	   the	  membrane	   [43].	   An	  uneven	  distribution	   of	   anionic	   phospholipids	   also	   plays	   an	   important	   role	   in	   creating	   the	   required	  electrical	  field	  [44].	  	  	  A	   transmembrane	   potential	   gradient	   has	   not	   been	   observed	   across	   the	   ER	   membrane	  although	   a	   small	   but	   significant	   Ca2+	   gradient	   is	   present	   [45].	   Still,	   the	   orientation	   of	  transmembrane	   segments	   inserted	   into	   the	   ER	   follows	   a	   ’rule’	   in	   which	   the	   charge	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distribution	   in	   the	   sequence	   immediately	   preceding	   the	   first	   transmembrane	   segment	  determine	  its	  orientation,	  with	  the	  more	  positive	  portion	  facing	  the	  cytosol	  [46].	  	  	  A	  peculiar	  but	  strong	  link	  exists	  between	  Spf1p	  and	  the	  way	  this	  process	  is	  taking	  place.	  In	  a	  screen	   devised	   to	   isolate	   yeast	   protein	   insertion	   orientation	   (pio)	   mutants	   defective	   in	  response	  to	  a	  strong	  charge	  difference	  signal,	  pio1	  was	  isolated	  and	  the	  corresponding	  gene	  found	  to	  be	  SPF1	  [47].	  The	  altered	  orientation	  of	  the	  reporter	  in	  the	  ER	  in	  the	  spf1	  background	  was	  explained	  by	  assuming	  a	  modified	  electrostatic	  field	  at	  the	  ER,	  as	  in	  this	  background	  the	  positively	  charged	  sequence	  flanking	  the	  single	  transmembrane	  segment	  of	  the	  reporter	  has	  changed	  orientation	   from	  the	  cytosolic	  side	  of	   the	  ER	  to	   the	   lumen	  (likewise,	   the	  negatively	  charged	  C-­‐terminal	  sequence	  had	  reverted	  to	  the	  cytosolic	  side	  of	  the	  membrane).	  In	  order	  to	  explain	  this	  phenotype,	  it	  would	  be	  expected	  that	  in	  spf1	  mutants,	  the	  luminal	  side	  of	  the	  ER	  is	  more	  negatively	  charged	  than	  in	  the	  wild-­‐type.	  Several	  ways	  by	  which	  Spf1p	  could	  contribute	  to	  creating	  a	  charge	  difference	  across	  the	  ER	  membrane	  are	  possible.	  One	  obvious	  possibility	  is	   that	   Spf1p	   is	   an	   electrogenic	   pump.	   If	   so,	   Spf1p	  may	   contribute	   to	   charge	   separation	   by	  transporting	  either	  positive	  charge	   into	  the	  ER	  lumen	  or	  negative	  charge	  from	  the	   lumen	  to	  the	  cytosol.	  	  It	   is	   worth	   mentioning	   that	   STE24,	   which	   encodes	   a	   metalloprotease	   integrated	   in	   the	   ER	  membrane	  that	  is	  involved	  in	  removal	  of	  the	  C-­‐terminal	  AAX	  tripeptide	  from	  prenylated	  CAAX	  box	  proteins	  such	  as	  the	  a-­‐factor	  [48],	  corresponds	  to	  PIO2,	  the	  second	  gene	  identified	  in	  the	  screen	  for	  genes	  of	  importance	  for	  protein	  insertion	  orientation	  [47].	  Interestingly,	  SPF1	  and	  
STE24	   show	   negative	   genetic	   interaction	  with	   each	   other	   [49-­‐52].	   In	  mammalian	   cells,	   ER-­‐bound	  metalloproteases	   function	  as	   sterol-­‐sensors	   that	  proteolytically	   release	   an	  ER-­‐bound	  transcription	  factor	  that	  activates	  genes	  involved	  in	  the	  biosynthesis	  or	  cholesterol	  and	  fatty	  acids	  [53].	  It	  has	  been	  suggested	  that	  Ste24p	  similarly	  is	   involved	  in	  the	  feedback	  control	  of	  sterol	   synthesis	   and	   that	   both	   Spf1p	   and	   Ste24p	   have	   in	   common	   that	   they	   indirectly	  contribute	  to	  control	  ER	  membrane	  lipid	  composition	  [47].	  	  	  4.3.2.	  Spf1p	  and	  membrane	  insertion	  of	  tail-­‐anchored	  proteins	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A	   specialized	   pathway	   has	   evolved	   for	   insertion	   into	   the	   ER	   of	   a	   sub-­‐group	   of	   membrane	  proteins	  with	  a	  single	  trans-­‐membrane	  segment	  [37].	  A	  relatively	  minor	  fraction	  (around	  5%)	  of	   eukaryotic	   membrane	   proteins	   have	   a	   single	   membrane	   span	   that	   is	   situated	   in	   their	  carboxy-­‐terminal	  end.	  Such	   ’tail-­‐anchored’	  (TA)	  membrane	  proteins	  perform	  many	  essential	  processes	  in	  the	  cell.	  Once	  synthesis	  of	  a	  TA-­‐protein	  is	   initiated	  on	  a	  ribosome,	  the	  carboxy-­‐terminal	  transmembrane	  domain	  is	  recognized	  by	  a	  protein	  complex,	  which	  in	  yeast	  involves	  Get3p,	  and	  is	  subsequently	  directed	  to	  the	  ER	  [54].	  Get1p	  and	  Get2p	  function	  as	  ER-­‐localized	  receptors	  for	  Get3p	  complexed	  with	  a	  TA	  membrane	  protein,	  and	  the	  protein	  is	  released	  in	  an	  ATP-­‐dependent	  manner	  while	  the	  carboxy-­‐terminal	  tail	  is	  inserted	  in	  the	  membrane	  [55].	  	  	  There	  are	  strong	  genetic	   links	  between	  SPF1	  and	  insertion	  of	  TA-­‐proteins	   into	  the	  ER.	  First,	  mutations	   in	  SPF1	   lead	  to	  synthetic	   lethality	   in	  combination	  with	  a	  disruption	  of	  GET1	   (also	  called	  MDM39)	   [56].	   Second,	   a	   deletion	   of	   SPF1	   is	   synthetic	   lethal	   in	   combination	   with	   a	  knockout	  in	  GET2,	  which	  encodes	  the	  second	  subunit	  of	  the	  TA-­‐protein	  receptor	  [57].	  Third,	  
SPF1	   shows	   negative	   genetic	   interactions	  with	  GET3	   [49,	   50,	   52].	   This	   implies	   that	   SPF1	   is	  acting	  genetically	  with	  all	  three	  members	  of	  the	  GET	  complex.	  	  Tail-­‐anchored	  membrane	  proteins	  destined	  for	  the	  mitochondrial	  outer	  membrane	  move	  into	  this	  membrane	   immediately	  after	  their	  synthesis	  and	  apparently	  do	  not	  require	  a	  dedicated	  machinery	  like	  the	  GET	  complex	  for	  membrane	  insertion	  to	  occur.	  Genes	  important	  for	  proper	  insertion	   of	   TA-­‐proteins	   in	   the	  mitochondrial	   outer	  membrane	  were	   identified	   in	   a	   screen	  employing	   Gem1p,	   a	   model	   TA-­‐protein	   in	   the	   mitochondrial	   outer	   membrane,	   which	   was	  fused	  to	  GFP	  and	  expressed	  in	  the	  background	  of	  all	  viable	  yeast	  deletion	  mutants.	  The	  only	  identified	  gene	  deletion	  that	  caused	  mislocalization	  of	  GFP-­‐Gem1p	  to	  the	  ER	  was	  SPF1	  [58].	  A	  closer	  investigation	  revealed	  that	  deletion	  of	  SPF1	  furthermore	  resulted	  in	  the	  mislocalization	  of	  other	  TA-­‐proteins	  from	  the	  mitochondrial	  outer	  membrane	  to	  the	  ER	  [58].	  	  	  Insertion	  of	  TA-­‐proteins	   into	  biological	  membranes	   is	   strongly	   inhibited	  by	  ergosterol	   [59],	  and,	   as	   the	  mitochondrial	   outer	  membrane	   has	   the	   lowest	   sterol	   content	   of	   all	  membranes	  exposed	  to	   the	  cytosol	   [60],	  a	  GET	  complex	  may	  not	  be	  required	   in	   this	  membrane.	  As	  cells	  deleted	   for	   SPF1	   have	   somewhat	   modified	   ergosterol	   levels	   in	   the	   mitochondrial	   outer	  membrane	  [58],	  Spf1p	  may	  in	  some	  way	  regulate	  sterol	  levels	  and	  the	  distribution	  of	  sterols	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in	   the	   cell.	   This	   function	  may	   have	   an	   impact	   on	   the	   ability	   of	   TA-­‐proteins	   to	   insert	   in	   the	  outer	  mitochondrial	  membrane	   and	   possibly	   also	   in	   the	   ER.	   Transfer	   of	   newly	   synthesized	  lipids	  including	  sterols	  into	  mitochondria	  takes	  place	  in	  mitochondria-­‐associated	  membranes	  (MAMs),	  a	  region	  of	  the	  ER	  in	  close	  proximity	  to	  the	  mitochondrial	  outer	  membrane	  [61].	  To	  our	  knowledge,	  Spf1p	  has	  not	  been	  identified	  in	  MAM	  structures	  but	  a	  role	  for	  P5A-­‐ATPases	  in	  regulating	  the	  circuit	  of	  sterols	  in	  MAMs	  cannot	  be	  excluded.	  
	  4.3.3.	  Spf1	  and	  translocation	  of	  secretory	  proteins	  across	  the	  ER	  membrane	  
	  Genetic	  evidence	  summarized	  below	  indicates	  that	  Spf1p	  is	  required	  to	  create	  a	  state	  of	   the	  ER	   in	  which	  post-­‐translational	   translocation	  of	  newly	  synthesized	  polypeptides	   through	   the	  ER	  membrane	  is	  optimally	  functioning.	  Proteins	  to	  be	  secreted	  enter	  the	  lumen	  of	  the	  ER	  in	  an	  unfolded	  state	  and	  pass	  through	  the	  translocon,	  an	  intricate	  machinery	  for	  post-­‐translational	  translocation	   of	   secretory	   proteins	   across	   the	   ER	   membrane	   [62].	   Two	   related	   translocon	  protein	  channels	  are	  the	  so-­‐called	  Sec61	  and	  the	  Ssh1	  (Sec	  sixtyone	  homologue1)	  complexes	  [63].	   Both	   are	   heterotrimeric	   complexes	   of	   three	   subunits	   (‘Sec61p,	   Sss1p,	   and	   Sbh1p’	   and	  ‘Ssh1p,	   Sss1p,	   and	   Sbh2p’,	   respectively)	   and	   associate	   with	   the	   regulatory	   Sec63	   complex	  made	  of	  four	  subunits	  (Sec62p,	  Sec63p,	  Sec71p,	  and	  Sec72p).	  	  	  
SPF1	   shows	   negative	   genetic	   interactions	   with	   SBH1,	   SBH2,	   and	   SSH1	   of	   the	   Sec61/Ssh1	  complexes	  [49,	  50,	  52]	  and	  with	  SEC62,	  SEC63,	  SEC66	  and	  SEC72	  of	  the	  Sec63	  complex	  [49,	  50-­‐52].	  We	  can	  conclude	  that	  in	  the	  absence	  of	  subunits	  of	  the	  translocon	  apparatus,	  the	  negative	  impact	   this	  has	  on	  growth	   is	   significantly	  aggravated	  when	  Spf1p	   is	   lacking.	  The	  Sec61	  and	  Ssh1	  translocons	  both	  play	  a	  role	   in	   the	  ER	  associated	  degradation	  pathway	  (ERAD)	   for	   the	  retro-­‐transport	   of	   misfolded	   proteins	   back	   into	   the	   cytosol	   where	   degradation	   in	   the	  proteasome	   occurs.	   Since	   Spf1p	   is	   part	   of	   the	   UPR	   and	   since	   in	   spf1	   mutants	   ERAD	   is	  malfunctioning	   [7],	   the	  genetic	   link	  with	   the	   translocons	   could	  be	  explained	  by	  a	   combined	  role	  in	  the	  retro-­‐transport	  of	  misfolded	  proteins.	  	  	  4.4.	  Spf1p	  and	  the	  biosynthesis	  and	  transport	  of	  sterols	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Among	   the	   important	   processes	   taking	   place	   in	   the	   ER,	   the	   biosynthesis	   of	   sterols	   and	  isoprenoids	  has	  a	  profound	  importance	  for	  a	  variety	  of	  cellular	  processes	  and	  defects	  in	  this	  process	  have	   a	   strong	   impact	   on	   the	  UPR	   [27].	  A	  number	  of	   independent	  observations	   link	  P5A-­‐ATPases	   to	   the	   biosynthesis	   and	   transport	   of	   sterols.	   A	   knockout	   of	   SPF1	   leads	   to	  sensitivity	   of	   yeast	   to	   inhibition	   of	   ergosterol	   synthesis	   [6,	   10,	   64],	   to	   loss	   of	   control	   in	  regulated	  degradation	  of	   ergosterol	   synthesis	   genes	   [6],	   and	   to	   an	  abnormal	  distribution	  of	  populations	  of	  ergosterol	  between	  the	  ER	  and	  mitochondria	  [58].	  Furthermore,	  a	  mammalian	  homologue,	  ATP13A1,	  has	  been	  identified	  in	  a	  screen	  for	  proteins	  that	  interact	  directly	  with	  cholesterol	  [65].	  	  3-­‐hydroxy-­‐3-­‐methyl-­‐glutaryl-­‐CoA	   reductase	   (HMG-­‐CoA-­‐reductase)	   catalyzes	   the	   most	  important,	   rate-­‐limiting	   step	   in	   the	   synthesis	   of	   sterols	   and	   isoprenoids,	   which	   is	   the	  reduction	  of	  hydroxymethylglutaryl-­‐CoA	  to	  mevalonic	  acid,	  a	  step	  which	  marks	  the	  beginning	  of	  the	  so-­‐called	  mevalonate	  pathway	  (Figure	  4).	  Two	  HMG-­‐CoA-­‐reductase	  isoenzymes,	  Hmg1p	  and	  Hmg2p,	  are	  responsible	  for	  HMG-­‐CoA-­‐reductase	  activity	  in	  ER	  membranes	  [66].	  Hmg1p	  is	  constitutively	   active	   while	   Hmg2p	   is	   only	   active	   when	   the	   demand	   for	   products	   of	   the	  mevalonate	   pathway	   is	   high.	   Otherwise,	   Hmg2p	   is	   degraded	   in	   the	   proteasome	   following	  ubiquitinylation	   in	  response	  to	   feedback	  signals	   from	  the	  mevalonate	  pathway.	  Accordingly,	  when	   feedback	   signals	   from	   the	   sterol	   pathway	   are	   high,	   Hmg2	   enters	   the	   degradation	  pathway.	  	  	  In	  a	  screen	  for	  mutants	  that	  constitutively	  degrade	  Hmg2p	  under	  conditions	  where	  feedback	  signals	   would	   normally	   be	   absent,	   38	   mutants	   isolated	   fell	   into	   a	   single	   complementation	  group,	  cod1	  (control	  of	  HMG-­‐CoA	  reductase	  degradation)	  [64].	  COD1	  was	  cloned	  and	  proved	  to	  be	  identical	  to	  SPF1	  [64].	  Growth	  of	  the	  cod1/spf1	  mutant	  was	  found	  to	  be	  hypersensitive	  to	  lovastatin,	  a	  HMG-­‐CoA-­‐reductase	  inhibitor,	  and,	  based	  on	  the	  normal	  response	  of	  the	  mutant	  to	  other	   inhibitors	  of	   enzymes	   in	   the	  mevalonate	  pathway,	   it	  was	   concluded	   that	   lovastatin	  hypersensitivity	  was	  specifically	  due	   to	  misregulation	  of	  Hmg2p	  [64].	  This	  was	  a	  surprising	  finding,	   because	   it	   could	   indicate	   that	   an	   intermediate	   of	   the	   mevalonate	   pathway	   is	  accumulating	  in	  the	  absence	  of	  Spf1p.	  We	  now	  know	  that	  ergosterol	  levels	  are	  indeed	  altered	  in	  the	  spf1	  mutant	  [58].	  Ergosterol	  by	  itself	  has	  only	  a	  minor	  effect	  on	  Hmg2p	  activity	  [67]	  but	  accumulation	   of	   this	   end	   product	   could	   influence	   the	   concentration	   of	   upstream	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intermediates	  that	  signal	  Hmg2p	  degradation.	  A	  deletion	  in	  ERG11,	   the	  enzyme	  in	  the	  sterol	  biosynthesis	   pathway	   immediately	   downstream	   of	   lanosterol	   (Fig.	   4),	   is	   synthetic	   lethal	   in	  combination	   with	   a	   deletion	   of	   SPF1	   [68].	   This	   may	   suggest	   that	   the	   Hmg2p	   degradation	  signal	  is	  formed	  further	  upstream	  in	  the	  pathway.	  	  	  Downstream	   in	   the	   mevalonate	   pathway,	   the	   formation	   of	   farnesyl	   pyrophosphate	   is	   the	  hallmark	  of	  the	  biosynthesis	  of	  sterols	  (Figure	  4).	  A	  major	  feedback	  signal	  that	  triggers	  HMG-­‐CoA-­‐reductase	   degradation	   is	   geranylgeranyl	   pyrophosphate,	   rather	   than	   a	   sterol	   [69].	   The	  enzyme	   that	   catalyzes	   the	   formation	   of	   geranylgeranyl	   pyrophosphate	   is	   Bts1p,	  which	   as	   a	  precursor	  employs	  farnesyl	  pyrophosphate.	  Remarkably,	  a	  deletion	  of	  BTS1	  is	  synthetic	  lethal	  in	  combination	  with	  a	  mutation	  in	  SPF1	  [56].	  Based	  on	  this	  evidence,	  we	  may	  assume	  that	  the	  mevalonate	   pathway	   compound	   that	   accumulates	   in	   the	   absence	   of	   Spf1p	   leads	   to	  accumulation	   of	   geranylgeranyl	   pyrophosphate	   (via	   farnesyl	   pyrophosphate)	   that	   in	   turn	  triggers	   degradation	   of	   Hmg2p,	   and	   as	   a	   result	   further	   lipid	   biosynthesis	   is	   prevented.	  However,	  in	  the	  absence	  of	  BTS1	  no	  geranylgeranyl	  pyrophosphate	  can	  be	  formed,	  whereas	  in	  the	   absence	   of	   SPF1	   geranylgeranyl	   pyrophosphate	   may	   accumulate.	   How	   would	   the	  combined	  loss	   lead	  to	  cell	   toxicity?	  An	  answer	  may	  be	  that	   if	  Hmg2p	  cannot	  be	  degraded	  in	  
spf1	  mutants	  lacking	  Bts1p,	  not	  only	  geranylgeranyl	  pyrophosphate	  accumulates,	  but	  also	  an	  end	   compound	   of	   mevalonate	   pathway,	   which	   in	   high	   concentrations	   may	   disturb	   ER	  functions	   and	   become	   lethal	   for	   the	   cell.	   Such	   a	   compound	   could	   be	   lanosterol	   and/or	  ergosterol	  (Figure	  4)	  as	  increased	  levels	  of	  both	  sterols	  result	  in	  rigidification	  of	  membranes	  [70,	   71].	   Further,	   farnesyl	   pyrophosphate	   derived	   lipids	   may	   destabilize	   Hmg2p	   [72,	   73].	  Taken	   together,	   it	   appears	   as	   if	   spf1	   cells	   somehow	   cannot	   redistribute	   one	   or	   more	  compounds	   in	   the	   mevalonate	   pathway,	   leading	   to	   accumulation	   and	   misregulation	   of	  feedback	  signals.	  	  A	   closer	   look	   at	   the	   enzymes	   involved	   in	   the	   sterol	   biosynthesis	   pathway	   in	   S.	   cerevisiae	  reveals	   that	   squalene	   synthase	   or	   Erg9p,	   which	   catalyzes	   the	   first	   committed	   step	   in	   the	  biosynthesis	  of	  ergosterol	  in	  yeast	  (Figure	  4),	  is	  a	  tail-­‐anchored	  protein	  [74,	  75].	  This	  enzyme	  catalyzes	   the	   condensation	  of	   two	  molecules	  of	   farnesyl	  pyrophosphate	   to	  produce	  a	   single	  molecule	  of	   squalene.	  As	  a	  TA-­‐protein,	  Erg9p	  might	  not	  end	  up	   in	   the	  ER	  membrane	   in	   the	  absence	  of	  Spf1p,	  which	  has	  strong	  genetic	  interactions	  with	  the	  receptor	  for	  TA-­‐proteins	  (see	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above).	   It	   seems	  clear	   from	  the	  above	  discussion	   that	   in	   the	  absence	  of	  Erg9p	  at	   its	   correct	  location,	   farnesyl	  pyrophosphate	  and	  subsequently	  geranylgeranyl	  pyrophosphate	  are	   likely	  to	  accumulate,	  which	  possibly	  could	  affect	  Hmg2p	  stability.	  	  Another	  possibility	  remains.	  If	  Spf1p	  is	  required	  in	  some	  way	  for	  the	  trafficking	  of	  ergosterol	  (or	  another	  end	  product	  of	  the	  mevalonate	  pathway)	  away	  from	  the	  ER,	  the	  absence	  of	  Spf1p	  would	  be	  predicted	  to	  result	  in	  the	  build-­‐up	  of	  ergosterol	  in	  the	  ER	  followed	  by	  accumulation	  of	   preceding	   intermediates.	   Accumulation	   of	   ergosterol	   (or	   another	   end	   product)	   may	  influence	  the	  properties	  of	  the	  ER	  membrane	  and	  affect	  negatively	  the	  spontaneous	  insertion	  of	   TA-­‐proteins,	   a	   process,	   which	   is	   sensitive	   to	   the	   sterol	   content	   of	   the	   membrane	   (see	  above).	  What	  comes	   first	   in	   the	  spf1	  mutant?	  A	  deficient	  TA-­‐protein	   insertion	  machinery	  or	  the	  accumulation	  of	  sterols?	  In	  our	  efforts	  to	  try	  and	  understand	  the	  genetic	  interaction	  data,	  we	  are	  thus	  faced	  with	  a	  ‘chicken-­‐or-­‐the-­‐egg’	  dilemma.	  	  Statins	   such	  as	   lovastatin	   target	  HMG-­‐CoA-­‐reductase	   and	   inhibit	  de	  novo	   sterol	   synthesis	  of	  sterols	  and	   isoprenoids	  [Kuranda	  et	  al.,	  2010].	  Such	  drugs	  exert	  multiple	  pleiotropic	  effects.	  Further,	  the	  mevalonate	  pathway	  is	  responsible	  for	  the	  production	  of	  numerous	  non-­‐steroid	  isoprenoids	  which	  isoprenylate	  essential	  intracellular	  proteins.	  These	  proteins	  include	  small	  GTPases,	   e.g.	   Ras	   and	   Rho	   GTPase	   families,	   which	   are	   known	   to	   connect	   intracellular	  signalling	  processes	  and	  extracellular	  stimuli.	  Many	  of	  the	  pleiotropic	  consequences	  of	  Spf1p	  loss	  could	  thus	  be	  due	  to	  secondary	  effects	  of	  a	  modified	  content	  of	  sterols	  and	  isoprenoids	  in	  the	   cell.	   As	   lovastatin	   treatment,	   which	   should	   reduce	   farnesyl	   pyrophosphate	   and	  geranylgeranyl	  pyrophosphate	  accumulation,	  does	  not	  affect	  Hmg2p	  degradation	  in	  an	  spf1∆	  mutant	  background	  [6,	  64],	  there	  may	  be	  alternative	  mechanisms	  for	  degradation	  of	  Hmg2p.	  In	   cells	   lacking	  SPF1,	  Hmg2p	  may	  be	  unresponsive	   to	   the	   in	  vivo	  degradation	   signal	  due	   to	  alterations	   in	   its	   structure	   that	   interfere	   with	   the	   degradation	   pathway	   [72,	   73].	   Such	  misfolding	   of	   Hmg2p	   in	   the	   absence	   of	   Spf1p	   may	   have	   the	   same	   origin	   as	   other	   protein	  folding,	  glycosylation,	  and	  insertion	  problems	  described	  in	  this	  review.	  	  4.5.	  Spf1p	  and	  post-­‐translational	  modification	  of	  secreted	  proteins	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After	  their	  synthesis	  and	  insertion	  in	  the	  ER,	  secreted	  proteins	  are	  often	  modified	  by	  addition	  of	   complex	   carbohydrate	   groups	   in	   the	   form	   of	   N-­‐linked	   glycosylation,	  glycophosphatidylinositol	   anchors,	   or	   O-­‐mannosylation.	   Spf1p	   appears	   to	   be	   influencing	   at	  least	  the	  first	  two	  of	  these	  processes.	  	  4.5.1.	  Spf1p	  and	  synthesis	  of	  glycosylphosphatidylinotisol	  membrane	  anchors	  	  A	  number	  of	   soluble	  proteins	   that	  are	   translocated	   into	   the	   lumen	  of	   the	  ER	  end	  up	  getting	  anchored	  to	  the	  luminal	  side	  of	  the	  ER	  membrane.	  Such	  proteins	  are	  typically	  secreted	  to	  the	  plasma	  membrane	   and	  many	   of	   them	   end	   up	   in	   the	   cell	   wall	   [77].	   The	  membrane	   anchor,	  which	  is	  attached	  to	  such	  proteins,	  is	  glycosylphosphatidylinotisol	  (GPI),	  a	  glycolipid	  found	  in	  all	   eukaryotic	   cells.	   GPI-­‐anchored	   proteins	   have	   in	  many	   cases	   been	   found	   associated	  with	  detergent-­‐resistant	  membrane	  domains	  in	  the	  plasma	  membrane,	  also	  called	  lipid	  rafts	  [78].	  GPI	  anchored	  proteins	  that	  end	  up	  bound	  to	  the	  cell	  wall	  do	  so	  as	  a	  result	  of	  a	  sugar	  group	  of	  GPI	  becoming	  covalently	  linked	  to	  β-­‐glucans.	  	  	  
SPF1	   shows	   strong	   genetic	   links	   with	   the	   last	   steps	   in	   the	   biosynthesis	   of	   GPI	   anchors,	   a	  process	  that	  takes	  place	  in	  the	  ER.	  Thus,	  mutations	  in	  GPI7	  (LAS21),	  that	  is	  involved	  in	  adding	  ethanolaminephosphate	  to	  the	  second	  mannose	  of	  GPI	  immediately	  before	  it	  is	  transferred	  to	  a	   protein,	   lead	   to	   synthetic	   lethality	   in	   combination	   with	   a	   disruption	   of	   SPF1	   [Ando	   and	  Suzuki,	  2005].	  Furthermore,	  SPF1	  shows	  negative	  genetic	  interaction	  with	  two	  subunits	  of	  the	  transamidase	  complex	  (GPI8	  and	  GPI17)	  [49,	  52],	  which	  catalyzes	  the	  transfer	  of	  the	  complete	  GPI	  precursor	  to	  proteins	  [79].	  The	  fact	  that	  SPF1	  shows	  a	  strong	  negative	  genetic	  interaction	  with	  the	  last	  steps	  of	  GPI	  anchor	  synthesis	  suggests	  that	  Spf1p	  influences	  a	  process	  upstream	  in	   the	   biosynthesis	   that	   can	   be	   compensated	   for	   by	   other	   means,	   but	   in	   the	   simultaneous	  absence	  of	  Spf1p	  and	  downstream	  components	  the	  process	  can	  no	  longer	  proceed.	  	  4.5.2.	  Spf1p	  and	  synthesis	  of	  N-­‐linked	  oligosaccharides	  	  Secreted	  proteins	  may	  be	  decorated	  in	  the	  ER	  by	  N-­‐linked	  glycosylation	  and	  the	  sugar	  moiety	  is	   subsequently	  modified	   in	   the	  Golgi.	   Secreted	   invertase	   isolated	   from	   spf1Δ	   cells	  migrates	  faster	  through	  SDS-­‐PAGE	  gels	  than	  does	  invertase	  secreted	  from	  wild-­‐type	  cells,	  which	  is	  an	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indication	  that	   it	   is	   less	  glycosylated	  [7,	  21].	  This	  was	  an	  early	  but	  strong	   indication	  that	  N-­‐linked	  glycosylation	  is	  influenced	  by	  Spf1p.	  	  
	  CPY*	   is	   a	   well-­‐characterized	  misfolded	  mutant	   of	   the	   secreted	   protein	   carboxypeptidase	   Y	  that	  following	  entry	  into	  the	  ER	  lumen	  is	  re-­‐exported	  to	  the	  cytosol	  for	  degradation	  [80].	  The	  
spf1	  mutant	  is	  defective	  in	  the	  degradation	  of	  CPY*	  but	  not	  Ste6p,	  a	  misfolded	  version	  of	  the	  plasma	  membrane	  protein	  [7].	  Characteristic	  for	  carboxypeptidase	  Y	  is	  that	  this	  protein	  is	  N-­‐glycosylated	   at	   several	   sites	   whereas	   Ste6p	   is	   not,	   and,	   importantly,	   CPY*	   has	   to	   carry	   a	  mature	   glycosylation	   pattern	   for	   efficient	   degradation	   [81].	   In	   pulse-­‐label	   experiments,	  Vashist	  et	  al.	  [7]	  could	  show	  that	  glycosylation	  of	  CPY*	  is	  normal	  in	  the	  spf1	  mutant	  whereas	  oligosaccharide	  trimming	  from	  Man9GlcNAc2	  to	  Man8GlcNAc2	  is	  compromised.	  The	  removal	  of	   one	   mannose	   residue	   from	   a	   glycosylated	   protein,	   converting	   the	   modification	   from	  Man9GlcNAc	  to	  Man8GlcNAc,	  is	  a	  trimming	  process	  catalyzed	  by	  α-­‐1,2-­‐mannosidase,	  Mns1p,	  and	  is	  the	  last	  step	  in	  glycoprotein	  maturation	  in	  the	  ER	  and	  a	  determining	  step	  in	  ER	  protein	  degradation.	   Apparently	   this	   lack	   of	   trimming	   is	   responsible	   for	   the	   inability	   of	   yeast	   to	  degrade	   CPY*	   in	   spf1	   cells.	   This	   correlation	   has	   not	   been	   tested	   and	   no	   genetic	   interaction	  between	  SPF1	  and	  MNS1	  has	  been	  reported.	  However,	  there	  are	  several	  reports	  on	  a	  negative	  genetic	  interaction	  between	  SPF1	  and	  RER1	  [49,	  50,	  52],	  which	  encodes	  a	  protein	  required	  for	  retention	  of	  Msn1p	  in	  the	  ER	  membrane	  [82].	  Mns1p	  itself	  is	  a	  single-­‐span	  membrane	  protein	  with	  its	  trans-­‐membrane	  segment	  situated	  in	  the	  extreme	  N-­‐terminus	  of	  the	  protein	  [82].	  As	  such	  it	  does	  not	  resemble	  the	  single-­‐span	  TA-­‐proteins	  discussed	  above,	  and	  at	  present	  we	  can	  not	  predict	  whether	  the	  lack	  of	  Spf1p	  influences	  the	  localization	  of	  Mns1p	  to	  the	  ER.	  	  4.6.	  Spf1	  and	  vesicle	  transport	  	  	  Secreted	  proteins	  that	  leave	  the	  ER	  inside	  the	  lumen	  of	  vesicles	  enter	  the	  Golgi	  and	  proceeds	  into	   the	   trans-­‐Golgi	   network,	   where	   they	   are	   sorted	   to	   proceed	   either	   to	   the	   plasma	  membrane	   or	   to	   the	   endosomal	   system	   [83].	   However,	   resident	   proteins	   of	   the	   ER	   are	  directed	   to	   their	   correct	   cisternal	   compartments	   in	   the	   Golgi	   by	   the	   so-­‐called	   conserved	  oligomeric	  Golgi	  (COG)	  complex,	  which	  mediates	  fusion	  of	  vesicles	  within	  the	  Golgi	  [84,	  85].	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SPF1	   show	   strong	  negative	   genetic	   interactions	  with	   several	  members	   of	   the	  COG	   complex,	  namely	  COG5,	  COG6,	  COG7,	  and	  COG8	  [49-­‐52,	  86].	  Together,	  Cog5p,	  Cog6p,	  Cog7p,	  and	  Cog8p	  form	  the	  so-­‐called	  lobe	  B	  of	  the	  COG	  complex	  [84].	  Lobe	  B	  is	   involved	  in	  directing	  late	  Golgi	  vesicle	   targeting	  and	   its	  subunits	   interact	  primarily	  with	  Rab	  and	  SNARE	  proteins	  [85].	   It	   is	  difficult	  to	  explain	  how	  the	  activity	  of	  Spf1p	  is	  linked	  to	  that	  of	  the	  COG	  complex.	  It	  is	  striking,	  however,	  that	  mutations	  in	  GET1	  as	  well	  as	   in	  GET2	  show	  synthetic	   lethality	  in	  combination	  with	  mutants	  in	  COG5,	  COG6,	  COG7,	  or	  COG8	  [57].	  As	  Get1p	  and	  Get2p	  form	  the	  ER	  receptor	  for	  TA-­‐proteins,	  which	   somehow	   is	   dependent	   on	   Spf1p	   activity	   (see	   above),	   the	   COG	   complex	  may	  be	  dependent	  on	   the	   correct	   insertion	  of	   a	  TA-­‐protein	   and	   this	  may	  explain	   its	   link	   to	  
SPF1.	  	  	  A	   number	   of	   other,	   seemingly	   unrelated,	   genes	   show	   strong	   links	   both	   to	   SPF1	   and	   genes	  encoding	  members	  of	  the	  GET	  complex.	  The	  list	  includes	  RIC1,	  BRE5,	  ERV14,	  OPI3,	  and	  RUD3.	  Among	  the	  encoded	  proteins,	  at	  least	  Ric1p,	  Bre5p,	  Erv14p,	  and	  Rud3p	  are	  involved	  in	  vesicle	  trafficking.	   Although	   these	   interactions	   may	   be	   relevant	   for	   our	   understanding	   of	   SPF1	  function,	   they	   may	   be	   indirect	   effects	   related	   to	   a	   dysfunctional	   GET	   complex	   and/or	   an	  altered	  content	  of	  sterol	  or	  isoprenoids	  in	  the	  secretory	  pathway.	  It	  is	  striking	  that	  a	  number	  of	   TA-­‐proteins	   are	   involved	   in	   vesicular	   transport	   [87],	   such	   as	   Bos1p,	   Bet1p,	   and	   Sec22p,	  which	  all	  are	  SNAP	  receptors	  (SNAREs)	  of	  the	  ER	  involved	  in	  vesicular	  transport	  from	  the	  ER	  to	  the	  Golgi	  [88],	  and	  Sed5p,	  which	  is	  a	  cis-­‐Golgi	  syntaxin	  that	  binds	  multiple	  SNARE	  proteins	  [89].	  Among	  these,	  SEC22	  appear	  to	  have	  several	  genetic	  interactions	  in	  common	  with	  SPF1.	  As	  expected,	  SEC22	  shows	  genetic	  interactions	  with	  GET1	  and	  GET2	  but	  it	  also	  exhibits	  strong	  genetic	  interactions	  with	  COG5	  to	  COG8,	  as	  well	  as	  with	  RUD3,	  ERV14,	  and	  BRE5	  [27,	  49-­‐52,	  90,	  91].	  	  	  As	   Spf1p	   appears	   to	   be	   required	   for	   a	   functional	   GET	   complex	   (see	   discussion	   above)	   it	   is	  tempting	   to	   speculate	   that	   in	   the	  absence	  of	  Spf1p,	   the	   insertion	   into	   the	  ER	  of	  Sec22p	  and	  functionally	   related	   TA-­‐proteins	   is	   compromised,	   which	   again	   leads	   to	   a	   weakening	   of	   the	  secretion	   machinery	   from	   the	   ER	   to	   the	   Golgi.	   For	   this	   reason,	   a	   mutation	   in	   SPF1	   in	  combination	  with	  mutations	   in	   genes	   involved	   in	   ER	   to	  Golgi	   transport	   (other	   than	  SEC22)	  would	  become	  a	  challenge	   for	  yeast	  growth.	   In	  support	  of	   this	  model,	  SEC22	   and	  SPF1	  both	  show	   strong	   genetic	   interactions	   with	   GLO3	   [27,	   49,	   52],	   which	   is	   not	   a	   TA-­‐protein	   but	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encodes	  an	  ADP-­‐ribosylation	  factor	  GTPase	  activating	  protein	  (ARF	  GAP)	  involved	  in	  vesicle	  transport	  from	  the	  ER	  to	  the	  Golgi	  [92].	  Furthermore,	  TA-­‐proteins	  constantly	  leak	  from	  the	  ER	  as	  they	  leave	  by	  transport	  vesicles	  heading	  for	  the	  Golgi	  and	  other	  post-­‐ER	  compartments	  and	  their	  retrieval	  is	  dependent	  on	  vesicle	  transport	  in	  the	  opposite	  direction	  [93].	  A	  deficiency	  in	  insertion	  of	  TA-­‐proteins	  in	  the	  ER	  membrane	  may	  be	  lethal	  in	  combination	  with	  a	  deficiency	  in	   vesicle-­‐mediated	   retrieval	   of	   lost	   TA-­‐proteins.	   This	   provides	   an	   additional	   link	   between	  membrane	   insertion	   of	   TA-­‐proteins	   and	   vesicle	   trafficking,	   both	   processes	   of	  which	   appear	  strongly	  linked	  to	  SPF1.	  	  4.7.	  Spf1	  and	  its	  influence	  on	  cell	  wall	  properties	  	  Unfolded	   proteins,	   impaired	   glycosylation	   and	   reduced	   GPI	   anchors	   may	   all	   contribute	   to	  impaired	  cell	  wall	  properties	  [94].	  As	  mentioned	  above,	  the	  initial	  discovery	  of	  SPF1	  was	  the	  result	   of	   a	   screen	  of	   yeast	  mutants	   that	   show	   tolerance	  of	  S.	  cerevisiae	  to	   the	   salt-­‐mediated	  killer	   toxin	   (SMKT)	   of	   the	   halotolerant	   yeast	   Pichia	   farinosa	   [21].	   Five	   sensitivity	   to	   Pichi	  
farinosa	  toxin	  (spf)	  mutants	  were	  isolated	  and	  all	  fell	  into	  the	  same	  complementation	  group,	  named	  spf1,	  and	  subsequently	  the	  SPF1	  gene	  was	  cloned.	  The	  spf1	  mutant	  cells	  were	  shown	  to	  be	  sensitive	  to	  calcofluor	  white	  and	  hygromycin	  B	  [21],	  two	  compounds	  that	  amplify	  the	  effect	  of	  cell	  wall	  mutations	  [95,	  96],	  which	  suggests	  that	  Spf1p,	  even	  though	  the	  protein	  is	  resident	  in	  the	  ER,	  in	  some	  way	  influences	  the	  properties	  of	  the	  yeast	  cell	  wall.	  	  Killer	  toxins	  are	  secreted	  proteins	  produced	  by	  so-­‐called	  killer	  yeast	  strains	  that	  kill	  sensitive	  (nonkiller)	   strains.	   The	   primary	   receptors	   of	   all	   yeast	   killer	   toxins	   characterized	   so	   far	   are	  localized	  to	  the	  cell	  wall	  [97].	  SMKT	  itself	  was	  found	  to	  interact	  with	  the	  cell	  wall	  [21],	  which	  would	  suggest	  that	  Spf1p	  in	  some	  way	  has	  an	  impact	  on	  the	  amount	  or	  the	  properties	  of	  an	  SMKT	  receptor	  at	  this	  position.	  Well-­‐characterized	  killer	  toxins	  are	  K1	  [98,	  99],	  produced	  by	  a	  
S.	  cerevisiae	  killer	   strain,	   and	  PMKT	   [100]	  produced	  by	  Pichia	  membranifaciens.	  Both	   toxins	  use	   β-­‐1,6-­‐D-­‐glucan	   as	   cell	   wall	   receptors	   before	   they	   enter	   the	   cell	   via	   interaction	   with	  secondary	  receptors,	  both	  of	  which	  are	  glycosylphosphatidylinositol	  (GPI)	  anchored	  proteins	  [reviewed	   in	   ref.	   97].	   In	   many	   cases,	   genes	   in	   S.	   cerevisiae	   that	   when	   mutated	   confer	  resistance	  to	  K1	  killer	  toxin	  encode	  enzymes	  involved	  in	  the	  synthesis	  of	  N-­‐glycans,	  which	  are	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complex	   polysaccharide	   structures	   present	   on	   many	   secreted	   and	   membrane-­‐bound	  glycoproteins	  [101].	  	  	  
P.	   farinosa	  SMKT	   is	   encoded	  by	   a	   single	   gene	   and	   is	   subsequently	   cleaved	   into	   two	  distinct	  subunits	  in	  a	  manner	  very	  similar	  to	  that	  of	  K1	  [102].	  However,	  SMKT	  kills	  S.	  cerevisiae	  kre1	  and	  kre5	  mutants	   being	  defective	   in	  β-­‐1,6-­‐D-­‐glucan	   synthesis,	  which	   suggests	   that	   cell	  wall	  components	  other	   than	  β-­‐1,6-­‐D-­‐glucan	   function	  as	   the	  primary	  receptor	   for	  SMKT	  [103].	  As	  the	   yeast	   cell	   wall	   is	   primarily	   made	   of	   only	   four	   components:	   β-­‐1,6-­‐glucan,	   β-­‐1,3-­‐glucan,	  mannoproteins	  and	  chitin	   [104,	  105],	   the	  number	  of	  alternative	  candidates	   for	  primary	  cell	  wall	  receptors	  seem	  limited.	  	  	  In	   this	   context,	   it	   is	   striking	   that	   a	   knockout	   of	   SMI1/KNR4,	   a	   protein	   involved in positive 
regulation of β-1,3-glucan synthesis [106],	  is	  synthetic	  lethal	  in	  combination	  with	  a	  knockout	  in	   SPF1	   [107,	   108].	   Like	   spf1	   mutants,	   smi1	   mutants	   are	   sensitive	   to	   calcofluor	   white	   and	  hydromycin	  B	  and,	  interestingly,	  smi1	  mutants	  are	  also	  resistant	  to	  K1	  killer	  toxin	  [101].	  This	  suggests	   that	   SPF1	   and	   SMI1	   by	   independent	   routes	   are	   required	   for	   efficient	   β-1,3-glucan 
synthesis,	  which	  explains	  why	  in	  the	  absence	  of	  both	  genes	  the	  effect	  is	   lethal.	  However,	  the	  action	  of	  Spf1p	  cannot	  be	  specifically	  required	  for	  formation	  of	  β-1,3-glucan as a	  mutation	  in	  
HOC1,	   which	   is	   a	   glycosyltransferase	   involved	   in	   formation	   of	   the	   hypermannose	   structure	  attached	   to	  mannoproteins,	   is	   also	   synthetic	   lethal	   in	   combination	  with	   a	  mutation	   in	  SPF1	  [108].	   This	   hints	   to	   the	   possibilities	   that	   the	   receptor	   for	   SMKT	   is	   either	   β-1,3-glucan or a 
mannoprotein in the cell wall. 	  	  The	   extremely	   high	   transformation	   efficiency	   of	   spf1	   mutant	   cells	   further	   reinforces	   the	  notion	   that	   Spf1p	   influences	   the	   properties	   of	   the	   cell	   wall	   [109].	   When	   viable	   deletion	  mutants	  of	  S.	  cerevisiae	  were	  transformed	  using	  a	  simplified	  lithium	  acetate	  method,	  spf1	  cells	  showed	  the	  highest	  transformation	  efficiency	  among	  around	  5,000	  mutants	  tested,	  and	  had	  a	  transformation	  efficiency	  and	  frequency	  almost	  two	  orders	  of	  magnitude	  higher	  than	  that	  of	  wildtype	   cells	   [109].	   Strikingly,	   the	   transformation	   efficiency	   of	   spf1	   cells	   compared	   to	  wildtype	  cells	  disappears	  when	   the	  cell	  wall	   is	   removed	  enzymatically	   [110].	  This	   indicates	  that	  an	  altered	  cell	  wall	  in	  spf1	  cells	  is	  an	  important	  determinant	  of	  the	  high	  capacity	  of	  these	  cells	  to	  absorb	  plasmid	  DNA.	  Whereas	  deletion	  of	  SPF1	  facilitates	  plasmid	  uptake,	  deletions	  in	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genes	  encoding	  proteins	   required	   for	   the	  endocytotic	  machinery	  diminishes	   transformation	  efficiency	  [109].	  The	  mutant	  with	  the	  second	  lowest	  transformation	  competence	  was	  arc18Δ,	  defective	  in	  encoding	  a	  subunit	  of	  the	  Arp2/3	  complex,	  which	  is	   involved	  in	  mediating	  actin	  assembly	   during	   endocytosis	   [109].	   SPF1	   shows	   a	   negative	   genetic	   interaction	  with	  ARC18	  [27]	  and	  the	  null	  mutant	  is	  synthetic	  lethal	  in	  combination	  with	  null	  mutations	  in	  two	  other	  Arp2/3	  subunits,	  ARP2	  and	  ARC40	  [108].	  This	  suggests	  that	  the	  cell	  wall	  deficiency	  caused	  by	  disruption	  of	  SPF1	  amplifies	  the	  aggravating	  effect	  of	  disturbing	  the	  endocytic	  machinery.	  
	  5.	  Towards	  a	  unifying	  hypothesis	  for	  the	  function	  of	  P5A-­‐ATPases	  	  Is	   it	   possible	   from	   the	   bewildering	   array	   of	   phenotypes	   of	   P5A-­‐ATPase	   mutants	   in	   model	  organisms	   to	   draw	   any	   conclusions	   on	   the	   function	   of	   these	   putative	   pumps?	  The	   fact	   that	  
SPF1	  encodes	   an	   ER	   protein	   but	   influences	   cell	   wall	   properties,	   reinforces	   the	   notion	   that	  deletion	  of	  SPF1	  has	  pleiotropic	  effects.	  The	  phenotype	  of	  spf1	  mutant	  cells	  is	  understandable	  if	   we	   consider	   that	   the	   cell	   wall	   consists	   of	   multiple	   proteins	   and	   polysaccharides	   that	  originate	   from	   the	   ER,	   and	   have	   passed	   through	   the	   secretory	   pathway	   to	   reach	   the	   cell	  exterior.	   Many	   of	   the	   proteins	   in	   the	   cell	   wall	   are	   GPI-­‐	   or	   tail-­‐anchored	   proteins	   and	  may	  require	   other	   post-­‐translational	   modifications	   by	   enzymes	   in	   the	   ER	   and	   the	   Golgi.	   Thus,	  disturbing	  ER	  homeostasis	  by	  mutating	  SPF1	  is	  likely	  to	  have	  a	  negative	  impact	  on	  the	  whole	  apparatus	  involved	  in	  cell	  wall	  formation.	  Following	  our	  analysis	  mainly	  of	  genetic	  interaction	  data	   it	   is	   possible	   to	   point	   to	   a	   role	   of	   Spf1p	   in	   most	   parts	   of	   the	   secretion	   machinery.	  However,	  some	  phenotypes	  stand	  out	  more	  than	  others	  and	  might	  indicate	  direct	  rather	  than	  indirect	  effects.	  First,	   there	   is	  a	  strong	   link	  between	  SPF1	  and	  the	   insertion	  of	   tail-­‐anchored	  proteins	   in	   membranes.	   Second,	   there	   are	   many	   indications	   that	   Spf1p	   influences	   the	  biosynthesis	  of	  a	  product	  in	  the	  mevalonate	  pathway.	  Third,	  it	  appears	  that	  Spf1p	  influences	  charge	  separation	  across	  the	  ER	  membrane.	  	  5.1	  Could	  Spf1	  be	  an	  ion	  pump?	  
	  Almost	  all	  P-­‐type	  ATPases	  transport	  cations,	  either	  out	  of	  the	  cytosol	  or	  into	  the	  cytosol	  [11].	  Thus,	  it	  seems	  an	  obvious	  hypothesis	  that	  Spf1p	  is	  an	  ion	  pump	  transporting	  positive	  charge	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into	  the	  ER	  lumen.	  Along	  this	  line,	  the	  substrate	  of	  Spf1p	  has	  been	  suggested	  to	  be	  Ca2+	  [6,	  7,	  64]	  or	  Mn2+	  [111].	  	  	  5.1.1	  Could	  Spf1p	  be	  a	  Ca2+	  pump?	  	  Several	  lines	  of	  evidence	  point	  to	  a	  connection	  between	  Spf1p	  and	  Ca2+	  levels	  in	  the	  ER.	  First,	  knockout	  of	  SPF1	  in	  S.	  cereviase	  and	  the	  related	  P5A-­‐ATPase	  genes	  in	  S.	  pombe	  (CTA4),	  and	  C.	  
albicans	  (SPF1)	  result	   in	  an	  induced	  Ca2+	  dyshomeostasis	  [6,	  9,	  112].	  Second,	  the	  deletion	  of	  
SPF1	   activates	   the	   Ca2+	   dependent	   calcineurin	   pathway	   [6].	   Third,	   the	   negatively	   charged	  residues	  in	  the	  putative	  substrate	  binding	  sites	  in	  the	  M4	  region,	  even	  though	  they	  only	  show	  weak	   similarity	   to	   Ca2+	   binding	   sites	   in	   other	   P-­‐type	   ATPases,	   could	   indeed	   be	   compatible	  with	   coordination	   of	   a	   cation	   like	   Ca2+.	   Fourth,	   the	   pleiotropic	   phenotype	   of	   P5A-­‐ATPase	  mutants	  is	  not	  at	  all	  incompatible	  with	  a	  role	  in	  regulation	  of	  Ca2+	  homeostasis	  in	  the	  ER.	  Fifth,	  we	   note	   that	  Mns1p,	   an	   enzyme	   residing	   in	   the	   ER	   lumen,	   is	   dependent	   upon	  Ca2+	  as	   a	   co-­‐factor	   [113,	  114]	  and	  appears	   to	  be	   inactive	   in	  spf1	   cells	   (see	  above)	  as	  expected	   if	   luminal	  Ca2+	  is	  decreased	  in	  this	  mutant.	  	  Whereas,	   in	   yeast,	   a	   Ca2+	   pump	  has	   never	   been	   identified	   in	   the	   ER,	   the	  Golgi	   apparatus	   is	  equipped	   with	   a	   Ca2+/Mn2+	   pump	   of	   the	   P-­‐type	   ATPase	   family	   named	   Pmr1p	   [115,	   116].	  Deletion	   of	   PMR1	   causes	   defects	   in	   protein-­‐linked	   oligosaccharide	   trimming	   and	   in	   outer	  chain	   modification	   of	   carbohydrates	   in	   the	   Golgi	   apparatus,	   which	   closely	   resemble	   the	  phenotypic	   consequences	   of	   deleting	   SPF1	   [7].	   It	   was	   therefore	   suggested	   that	   Pmr1p	   and	  Spf1p	  carry	  out	  identical	  functions	  but	  in	  different	  compartments	  [7].	  In	  support	  of	  this	  notion	  is	  that	  SPF1	  in	  several	  other	  experiments	  have	  shown	  negative	  genetic	  interaction	  with	  PMR1	  [47,	  49,	  50,	  52].	  	  Although	   it	   is	   tempting	   to	   think	  of	  Spf1p	  as	  a	  Ca2+	  pump	  of	   the	  ER,	  we	  need	   to	  be	   cautious	  before	  we	  draw	  such	  a	  conclusion.	  The	  physiological	  effects	  caused	  by	  loss	  of	  Spf1p	  function	  are	   not	   necessarily	   primary	   effects	   but	   could	   result	   from	   Ca2+	   related	   stress	   responses,	   or	  other	  indirect	  effects	  that	  lead	  to	  loss	  of	  the	  ability	  to	  control	  Ca2+	  homeostasis.	  In	  fact,	  several	  lines	  of	  evidence	  argue	  against	  Ca2+	  being	  the	  substrate	  of	  Spf1p.	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First,	  knockout	  of	  SPF1	  in	  C.	  albicans	  only	  affect	  cellular	  Ca2+	  levels	  in	  the	  presence	  of	  agents	  that	  modulate	  Ca2+	  stress	  in	  which	  case	  both	  the	  cytoplasmic	  and	  total	  cellular	  calcium	  levels	  significantly	   increase	   [112].	   Similarly,	   the	   total	   calcium	   content	   of	   the	   SPF1	   knockout	   in	   S.	  
cerevisiae	   remains	   comparable	   to	   the	   wild	   type	   strain	   and	   a	   synergistic	   increase	   in	   total	  cellular	  calcium	  content	  is	  only	  observed	  when	  simultaneously	  paired	  with	  disruption	  of	  the	  Golgi	  apparatus-­‐localized	  Ca2+	  pump	  Pmr1p	  [6].	  Genetic	  deletion	  of	  the	  SPF1	  homologue	  in	  S.	  
pombe,	  CTA4,	  also	  leads	  to	  loss	  of	  microtubule	  integrity	  and	  altered	  nuclear	  Ca2+	  homeostasis	  [9],	   which	   can	   be	   ascribed	   to	   altered	   transport	   of	   calcium	   across	   the	   ER	  membrane	   [117].	  However,	   whether	   this	   effect	   is	   caused	   by	   compensatory	   mechanisms,	   for	   instance	   by	  increased	   activity	   of	   the	   Ca2+/Mn2+	   transporting	   P2-­‐type	   ATPase	   also	   found	   in	   the	   ER	   of	   S.	  
pombe	  [118],	  or	  if	  it	  is	  caused	  directly	  by	  loss	  of	  Cta4p	  function	  remains	  unclear.	  	  	  Second,	   as	   Spf1p	   belongs	   to	   the	   P-­‐type	   family	   of	   ATPases,	   which	   as	   a	   hallmark	   get	  phosphorylated	  or	   dephosphorylated	   in	   the	   catalytic	   cycle	   upon	  binding	   of	   the	   transported	  substrate,	  it	  is	  remarkable	  that	  Ca2+	  fails	  to	  change	  the	  phosphorylation	  status	  of	  Spf1p	  [119]	  and	  only	  seems	  to	  affect	  its	  counterpart	  in	  plants	  in	  a	  non-­‐catalytically	  relevant	  manner	  [120].	  Neither	   have	   Ca2+-­‐dependent	   ATPase	   activity	   or	   phosphorylation	   of	   any	   P5A-­‐ATPase	   been	  demonstrated,	  despite	  serious	  efforts	  on	  both	  Spf1p	  purified	  from	  S.	  cerevisiae	  [6,	  119]	  or	  on	  the	  plant	  homologue	  HvP5A1	  from	  H.	  vulgare	  [120].	  In	  the	  case	  of	  Spf1p,	  work	  was	  carried	  out	  on	  a	  purified	  and	  solubilized	  enzyme	  which	  retained	  ATP	  hydrolytic	  activity	  [6]	  and	  displayed	  phospho-­‐enzyme	  formation	  [119]	  comparable	  to	  most	  other	  P-­‐type	  ATPases.	  Remarkably	  this	  activity	   was	   observed	   in	   the	   absence	   of	   any	   added	   ligand	   other	   than	   Mg2+	   and	   ATP	   and	  addition	  of	  Ca2+	   showed	  no	  effect	  on	  kinetic	  parameters	  at	   low	  but	  physiologically	   relevant	  concentrations	  (>50	  µM)	  [6,	  119].	  Further,	  the	  fact	  that	  Ca2+	  causes	  a	  slight	   inhibitory	  effect	  on	  ATP	  turnover	  at	  higher	  (non-­‐physiological)	  concentrations	  (<	  500	  µM)	  [6]	  is	  not	  in	  favour	  of	   Ca2+	   as	   a	   transported	   ligand.	   In	   the	   case	   of	   HvP5A1,	   phosphoenzyme	   formation	   and	  turnover	  was	  studied	  in	  isolated	  intact	  membranes	  carrying	  the	  P5A-­‐ATPase	  in	  a	  native	  lipid	  environment	   and,	   in	   agreement	   with	   Spf1p	   [119],	   the	   HvP5A1	   phosphoenzyme	   formation	  happens	  spontaneously	  without	  addition	  of	  cofactors	  other	  than	  ATP	  and	  Mg2+	  [120].	  Among	  all	   ions	   required	   for	   plant	   growth	   only	   Ca2+	   affects	   phosphoenzyme	   stability	   of	   HvP5A1	  although	   this	   effect	   is	   only	   observed	   at	   high	   apparent	   concentrations	   of	   Ca2+	   (~500	   µM).	  Moreover,	   this	   high	   Ca2+	   effect	   is	   also	   observed	   when	   the	   catalytic	   machinery	   for	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phosphoenzyme	   turnover	   is	   inactivated	   by	   mutation	   [20],	   which	   implies	   that	   Ca2+	   merely	  affects	   phosphoenzyme	   stability	   rather	   than	   catalytic	   turnover	   and	   that	   the	   Ca2+	   effect	   is	  unrelated	  to	  the	  transport	  function	  of	  the	  P5A-­‐ATPases.	  	  	  Third,	   the	   insertion	  of	  TA-­‐proteins	   in	   the	  mitochondrial	   outer	  membrane	   is	  not	   affected	  by	  either	  Ca2+	  or	  calcineurin	  [58]	  even	  though	  this	  process	  is	  strictly	  dependent	  on	  Spf1p	  activity	  (see	  discussion	  above).	  	  Fourth,	   and	   not	   least,	   when	   yeast	   cells	   are	   grown	   on	   a	   medium	   containing	   strontium,	   a	  calcium	  analogue,	  the	  SPF1	  knockout	  accumulates	  significantly	  more	  Sr90	  than	  wild	  type	  cells	  [121].	  In	  fact,	  among	  4,862	  mutant	  strains	  tested,	  spf1Δ	  exhibited	  one	  of	  the	  highest	  degrees	  of	   Sr90	   accumulation.	   In	   this	   context	   it	   is	   noteworthy	   that	   disruption	   of	   genes	   known	   to	   be	  involved	  in	  Ca2+	  transport	  resulted	  in	  decreased	  Sr90	  levels.	  This	  included	  mutations	  in	  CCH1	  and	   VCX1,	   encoding	   a	   plasma	   membrane	   Ca2+	   channel	   and	   a	   vacuolar	   Ca2+	   antiporter,	  respectively,	   and	   the	   strongest	   decrease	   was	   seen	   for	   a	   mutants	   in	   PMC1	   encoding	   the	  vacuolar	  Ca2+-­‐pump.	  This	  illustrates	  that	  although	  SPF1	  contributes	  to	  the	  Ca2+	  homeostasis	  of	  yeast	   cells,	   it	   does	   so	   in	   an	   opposing	   way	   as	   well	   characterized	   Ca2+	   transporters.	   Taken	  together	  the	  available	  data	  strongly	  suggest	  that	  Ca2+	  is	  not	  the	  transported	  ligand	  of	  Spf1p	  or	  any	  other	  P5A-­‐ATPase.	  	  	  Having	  this	  in	  mind,	  we	  might	  be	  able	  to	  provide	  an	  alternative	  explanation	  for	  the	  negative	  genetic	   interaction	   between	  SPF1	   and	  PMR1.	  Membrane	   vesicle	   traffic	   between	   the	   ER	   and	  Golgi	  is	  bi-­‐directional	  and	  proteins	  involved	  in	  trafficking,	  as	  well	  as	  ER-­‐resident	  proteins	  that	  have	   escaped	   the	   ER	   retention	   system,	   are	   continuously	   packaged	   into	   COPI	   vesicles	   and	  retrieved	  back	   to	   the	  ER	  [122,	  123].	  We	  may	  assume	  that	  concentrations	  of	   ions	   in	  vesicles	  leaving	  the	  Golgi	   towards	  the	  ER	  are	   identical	   to	  those	  of	   the	  Golgi	   lumen.	  This	   implies	  that	  the	  activity	  of	  Pmr1p,	  even	  though	  it	  is	  resident	  in	  the	  Golgi	  only,	  might	  well	  be	  sufficient	  to	  provide	  all	  the	  Ca2+	  and/or	  Mn2+	  required	  for	  processes	  in	  the	  ER	  [45].	  	  	  5.1.2	  Could	  Spf1p	  be	  a	  Mn2+	  pump?	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It	  was	  recently	  proposed	  that	  Spf1p	  might	  transport	  Mn2+	  from	  the	  cytosol	  into	  the	  ER	  lumen	  [111].	  In	  support	  of	  this	  model,	  membrane	  vesicles	  isolated	  from	  spf1Δ	  cells	  show	  less	  Mn2+	  than	  vesicles	   isolated	  from	  wild	  type	  cells,	  whereas	  vesicles	   from	  Spf1p	  overproducing	  cells	  show	   higher	   levels	   of	   Mn2+.	   Furthermore,	   many	   proteins	   involved	   in	   processes	   in	   the	  secretory	   pathway	   that	   can	   be	   linked	   to	   Spf1p	   action	   are	  Mn2+	   dependent	   enzymes	   [111].	  Arguing	   against	   this	   possibility	   is	   the	   fact	   that	   Mn2+	   inhibits	   ATP	   hydrolytic	   activity	   of	  partially	  purified	  Spf1p	  [119]	  and	  fails	  to	  significantly	  influence	  the	  phosphorylation	  status	  of	  the	   Spf1p	   counterpart	   in	   plants	   in	   a	   catalytically	   relevant	   manner	   [120].	   A	   peculiar	  phenomenon,	   which	   appears	   difficult	   to	   explain	   by	   a	   role	   of	   Spf1p	   in	   Mn2+	   transport	   but	  rather	  points	   to	   indirect	   effects,	   is	   that	   the	  Zn2+	   content	   in	  microsomes	  derived	   from	   spf1Δ	  cells	  is	  an	  order	  of	  magnitude	  higher	  than	  that	  found	  in	  the	  wildtype	  whereas	  overexpression	  of	  Spf1p	  has	  no	  effect	  on	  Zn2+	  accumulation	  [111].	  	  	  5.1.3	  Could	  Spf1p	  be	  a	  Mg2+	  pump?	  	  As	  discussed	  above,	  Mg2+	   is	   the	  only	   cation	   required	   to	   stimulate	  ATP	  hydrolytic	  activity	  of	  Spf1p	  [119]	  and	  phosphoenzyme	  formation	  in	  the	  plant	  P5A-­‐ATPase	  HvP5A1	  [120].	  All	  P-­‐type	  ATPases	  require	  Mg2+	  for	  proper	  ATP	  coordination	  and	  phosphorylation	  of	  the	  conserved	  Asp	  in	  the	  P-­‐domain	  [11].	  The	  kinetics	  of	  Mg2+	  dependence	  on	  the	  above	  reactions	  [119,	  120]	   in	  both	   cases	   seem	   to	   be	   similar	   to	   that	   of	   other	   P-­‐ATPases	   where	   Mg2+	   acts	   as	   a	   cofactor.	  Although	  it	  cannot	  be	  ruled	  out	  that	  in	  P5A-­‐ATPases	  an	  additional	  role	  of	  Mg2+	  is	  to	  serve	  as	  a	  transported	  ligand,	  so	  far	  no	  available	  evidence	  support	  this	  conclusion.	  	  5.2	  Could	  Spf1	  be	  an	  ER	  lipid	  flippase?	  	  As	  an	  alternative	  hypothesis	  to	  Spf1p	  action	  it	  has	  been	  suggested	  that	  it	  flips	  a	  lipid	  species	  or	   any	   other	   organic	   molecule	   across	   the	   ER	   membrane	   bilayer,	   in	   analogy	   with	   the	  phospholipid	   flipping	   P4-­‐ATPases,	   that	   among	   P-­‐type	   ATPases	   are	   phylogenetically	   most	  closely	   related	   to	  P5-­‐ATPases	   [124].	   The	  ER	   is	   the	   only	  membrane	   system	  of	   the	   secretory	  pathway	  in	  which	  lipid	  flippases	  have	  not	  been	  characterized.	  In	  other	  membrane	  systems	  of	  the	  cell	  the	  activity	  of	  P4-­‐ATPases	  cause	  local	  imbalances	  in	  the	  number	  of	  phospholipids	  on	  each	   side	   of	   the	   membrane,	   and	   such	   an	   activity	   has	   been	   hypothesized	   to	   provoke	   a	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deformation	   of	   the	   membrane	   that	   can	   be	   stabilized	   by	   other	   proteins	   and	   constitute	   the	  initial	  formation	  of	  membrane	  vesicles	  [124,	  125].	  	  	  Should	   Spf1p	   catalyse	   a	   flippase	   activity	   its	   role	   may	   not	   be	   restricted	   to	   generation	   of	  membrane	  vesicles.	  It	  has	  been	  hypothetized	  that	  the	  activities	  of	  lipid	  flippases	  in	  the	  ER	  is	  required	   to	   provide	   building	   blocks	   for	   the	   synthesis	   of	   N-­‐linked	   oligosaccharides	   or	   GPI	  anchors	   [126-­‐128].	   N-­‐linked	   glycosylation	   and	   other	   processes	   that	   involve	   carbohydrate	  modifications	  of	  proteins	  take	  place	   in	  the	   lumen	  of	  the	  ER	  and	  the	  Golgi.	  The	  carbohydrate	  precursors	  are	  glycolipids	  that	  likewise	  are	  integrated	  in	  the	  luminal	  leaflet	  of	  the	  membranes	  of	  the	  ER.	  However,	  biosynthesis	  of	  these	  glycolipid	  precursors	  is	  initiated	  by	  enzymes	  in	  the	  cytosol	   that	  only	  work	  on	  a	  substrate	  on	   the	  cytosolic	   leaflet	  of	   the	  ER.	  This	   implies	   that	  at	  some	  stage	  of	  their	  biosynthesis,	  glycolipid	  intermediates	  have	  to	  traverse	  the	  ER	  membrane	  by	  moving	  from	  one	  leaflet	  to	  the	  other	  (a	  process	  termed	  flipping).	  	  	  At	   least	   three	   lipids	   required	   for	   carbohydrate	   modification	   of	   proteins	   have	   been	  hypothesized	   to	   flip	   across	  ER	  membranes	   [128]:	   i)	  Man5GlcNAc2-­‐PP-­‐dolichol	   (M5-­‐DLO);	   ii)	  glucosaminyl-­‐acyl-­‐PI	  (GlcN-­‐acyl-­‐PI	  or	  GPI);	  and	   iii)	  mannose-­‐phosphate-­‐dolichol	  (MPD).	  The	  enzymes	   carrying	   out	   these	   flippase	   reactions	   have	   only	   been	   poorly	   characterized	   and	   no	  genes	   encoding	   such	   flippases	   have	   been	   identified.	   However,	   from	   reconstitution	  experiments	  it	  appears	  that	  MPD,	  M5-­‐DLO	  and	  glycerophospholipid	  flipping	  are	  independent	  activities	  that	  require	  distinct	  proteins	  in	  the	  ER	  membrane	  [128].	  	  	  There	   are	   at	   least	   two	   arguments	   against	   the	   role	   of	   Spf1p	   in	   the	   above	  described	   flippase	  activities.	  First,	  all	  of	  the	  mentioned	  flippase	  processes	  appear	  to	  be	  ATP	  independent	  [128]	  whereas	  Spf1p	  hydrolyzes	  ATP	  [119].	  Second,	  in	  most	  eukaryotic	  organisms,	  only	  a	  single	  ER	  Spf1p	  homologue	  is	  present	  [120].	  This	  appears	  to	  be	  incompatible	  with	  a	  specific	  role	  in	  at	  least	   three	  distinct	  processes.	  Still,	  we	  cannot	  rule	  out	   the	  possibility	   that	  Spf1p	  catalyzes	  a	  lipid	   flippase	   activity	   in	   the	   ER,	   which	   is	   distinct	   from	   the	   three	   mentioned	   above,	   but	  required	   in	  some	  way	   for	  vesicle	  generation,	   lipid	  recycling,	  and/or	   lipid	  distribution	   in	   the	  ER.	  	  6.	  Major	  conclusions	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  The	  pleiotropic	  phenotype	  of	  spf1	  cells	  indicate	  that	  loss	  of	  its	  function	  leads	  to	  impairment	  of	  basic	  ER	  processes	  such	  as	  protein	  folding	  and	  processing.	  In	  the	  plant	  Arabidopsis	  thaliana,	  disruption	  of	  the	  single	  P5A-­‐ATPase	  gene,	  AtP5A1/MIA/PDR2,	  also	  correlates	  with	  sensitizing	  of	   a	   subset	   of	   ER	   quality	   control	   responses	   [10,	   29].	   Further,	   the	   knockout	   of	  
AtP5A1/MIA/PDR2	   results	   in	  mutant	  plants	  with	  decreased	   fertility	   due	   to	   collapsed	  pollen	  grains	  [10],	  as	  well	  as	  inability	  to	  maintain	  root	  stem	  cells	  during	  limiting	  Pi	  conditions	  [29].	  Whether	  this	  effect	  can	  be	  attributed	  to	  a	  disturbed	  ER	  equilibrium	  is	  not	  known.	  	  A	   putative	   role	   of	   Spf1p	   in	   the	   vesicular	   communication	   between	   the	   Golgi	   and	   the	   ER	   is	  evident	   from	   the	   analysis	   of	   genetic	   interactions	   above.	   An	   important	   role	   of	   Spf1p	   in	   this	  route	  could	  explain	  the	  Ca2+	  phenotype	  spf1	  in	  combination	  with	  pmr1,	  could	  explain	  defects	  in	  folding,	  sorting,	  glycosylation,	  and	  ergosterol	  distribution,	  and	  maybe,	  as	  a	  consequence	  of	  ergosterol	   accumulation	   in	   the	   ER,	   explain	   how	   it	   plays	   a	   role	   in	   TA-­‐protein	  insertion/localization.	  	  So	  why	  would	  isolated	  P5A-­‐ATPase	  protein	  spontaneously	  hydrolyse	  ATP,	  apparently	   in	  the	  absence	   of	   any	   obvious	   ligand,	   and	   what	   would	   then	   be	   the	   transport	   substrate	   of	   P5A-­‐ATPases?	  	  	  First,	   the	   spontaneous	   formation	   of	   the	   phosphoenzyme	   corresponds	   to	   the	   biochemical	  behaviour	  of	  other	  P-­‐type	  ATPases,	  which	  do	  not	  require	  binding	  of	  a	  transport	  substrate	  to	  carry	  out	  pump	  phosphorylation.	  These	   include	  the	  phospholipid	   flipping	  P4-­‐ATPases	  [129]	  and	   some	  heavy	  metal	   pumping	  P1B-­‐1	  ATPases	   [130].	   Second,	   it	   remains	   possible	   that	   the	  coupling	  mechanism,	  which	  is	  required	  for	  communication	  between	  the	  transport	  binding	  site	  in	   the	   membrane	   and	   the	   nucleotide	   binding	   pocket	   in	   the	   cytoplasmic	   P	   domain,	   is	   lost	  during	  purification	  resulting	  in	  uncoupling	  of	  the	  pump.	  	  	  It	  remains	  a	  possibility,	  however,	  that	  a	  substrate	  is	  already	  present	  in	  the	  reported	  enzyme	  preparations.	  Should	  this	  be	  the	  case,	  the	  substrate	  likely	  constitutes	  a	  component	  associated	  with	  the	  membrane	  itself.	  This	  could	  be	  any	  organic	  molecule,	  such	  as	  a	  lipid	  or	  small	  peptide	  fragment.	  The	  accumulation	  of	  P5A-­‐ATPase	   in	  the	  E1P	  state	  would	  at	   least	   indicate	  that	   the	  
	   29	  
substrate	   in	   the	   membrane	   preparations	   is	   limiting	   or	   that	   other	   regulatory	   factors	   are	  needed	  to	  activate	  phosphoenzyme	  turnover.	  	  7.	  	  General	  significance	  	  It	   is	  our	  hope	  that	   this	  review	  will	  create	   ideas	   for	   further	  studies	  aiming	  at	  elucidating	  the	  role	  of	  P5A-­‐ATPases,	  a	  mysterious	  group	  of	  primary	  active	  pumps	  that	  still	  have	  no	  assigned	  function	   despite	   the	   fact	   that	   they	   are	   ubiquitously	   present	   in	   eukaryotic	   and	   are	   likely	   to	  carry	  out	  an	  important	  basic	  process	  in	  the	  machinery	  of	  the	  cell.	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Figure	  legends	  	  	  Figure	  1.	  Overview	  of	  P5	  ATPase	  primary	  structure.	  P5	  ATPases	  contains	  archetypical	  P-­‐type	  motifs	   including	  the	  DKTG	  motif	   in	  the	  P	  domain,	  the	  KGAPE	  motif	   in	  the	  N	  domain	  and	  the	  TGE	  motif	  in	  the	  A	  domain.	  Whereas	  most	  P-­‐type	  ATPases	  typically	  have	  10	  transmembrane	  helics,	  P5A-­‐ATPases	  are	  predicted	  to	   include	  12	  transmembrane	  helices	  with	  two	  additional	  helices,	  Ma	  and	  Mb,	  in	  the	  N-­‐terminal	  end)	  [129].	  The	  P5	  specific	  motif	  PPxxP	  located	  in	  M4	  shows	  conservation	  of	  charged	  residues	  in	  P5A-­‐ATPases	  (PP(E/D)LPM(E/D))	  [3].	  The	  insert	  identified	  in	  P5A	  primary	  sequences	  between	  the	  Mg2+	  binding	  site	  and	  the	  M5	  extended	  stalk	  helix	  [5]	  (motifs	  shown)	  is	  marked	  with	  an	  asterisk.	  	  	  Figure	   2.	   Interaction	   data	   for	   309	   genetic	   interactions	   for	   SPF1	   and	   its	   encoded	   protein	  identified	   in	   the	   Saccharomyces	   cerevisiae	   genome	   database	   (http://yeastgenome.org).	   A)	  The	  highest	   ranking	   interactors	   (identified	   in	  at	   least	  5	   independent	  experiments)	  group	  as	  clusters	  around	  members	  of	  the	  GET	  complex.	  B)	  Cellular	  location	  of	  interactors.	  The	  majority	  of	  interactors	  (~36%)	  are	  present	  in	  the	  secretory	  pathway.	  C)	  Functional	  role	  of	  interactors.	  The	  majority	  of	  interactors	  (~28%)	  plays	  a	  role	  in	  vesicle	  trafficking	  and	  transport.	  	  	  	  Figure	  3.	  Summary	  of	  the	  function	  and	  cellular	  localization	  of	  major	  proteins	  which	  activities	  are	   related	   to	   Spf1p.	   Orange	   colour	   depicts	   proteins	   encoded	   by	   genes	   that	   show	   genetic	  interaction	  with	  SPF1	  (spf1p	  encoded	  in	  grey).	  The	  major	  functions	  includes:	  A)	  the	  unfolded	  protein	   response,	   B)	   tail	   anchored	   protein	   insertion,	   C)	   protein	   translocation,	   D)	   protein	  insertion	   orientation,	   E)	   sterol	   synthesis	   and	   transport,	   F)	   glycophosphatidylinositol	  synthesis	   and	   modification	   and	  G)	   protein	   glycosylation.	   See	   text	   for	   further	   explanations.	  UPR:	  unfolded	  protein	  response,	  TA:	  tail	  anchored,	  SRP:	  signal	  recognition	  particle,	  reporter:	  reporter	   used	   to	   study	   protein	   insertion	   phenotype	   in	   [47],	   GGPP:	   Geranylgeranyl	  pyrophosphate,	   FPP:	   farnesyl	   pyrophosphate,	   EtNP:	   ethanolaminephosphate,	   GPI:	  glycosylphosphatidylinositol.	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Figure	  4.	  Abbreviated	  ergosterol	  biosynthesis	  pathway.	  Principal	  intermediates	  and	  enzymes	  are	  shown.	  Red	  lines	  indicate	  inhibitory	  actions	  by	  inhibitory	  molecules.	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Figure	  1.	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Figure	  2.	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Figure	  3.	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Figure	  4.	  	  	  
	   	  
Synonyms of interactor
Systematic Name Spf1 
Interactor (Spf1 = YEL031W) Spf1 interactor
No. of genetic 
interactions
- YLR153C ACS2 2
SAT2 YIL044C AGE2 1
- YPL158C AIM44 1
ECM39 YNR030W ALG12 1
- YOR002W ALG6 3
YOR29-18 YOR067C ALG8 2
- YLR370C ARC18 1
- YBR234C ARC40 2
ACT2 YDL029W ARP2 2
- YLR242C ARV1 3
- YGR177C ATF2 1
- YIL124W AYR1 1
LAS3|SSP31|SAP3|SLK1 YJL095W BCK1 3
SRO1 YBR200W BEM1 1
IPL2|SUP9|TSL1 YER155C BEM2 1
- YHR101C BIG1 2
APR6 YER177W BMH1 1
- YCR032W BPH1 1
- YDL074C BRE1 1
CPS60 YLR015W BRE2 1
- YNR051C BRE5 5
PER17 YFL025C BST1 1
- YPL069C BTS1 2
PAC7 YMR055C BUB2 1
- YLR418C CDC73 3
MMS8 YDL164C CDC9 1
USA4 YNL192W CHS1 2
CSD2|KTI2|DIT101|CAL1 YBR023C CHS3 1
- YHR142W CHS7 1
- YMR198W CIK1 2
UGX1|GTP1 YMR138W CIN4 1
YOR29-12 YOR061W CKA2 1
- YOR039W CKB2 1
ERC10 YNL298W CLA4 1
- YPL256C CLN2 1
YCN2|CRV1 YKL190W CNB1 2
FUN48 YAL058W CNE1 2
API4|COD4 YNL051W COG5 3
SEC37|COD2 YNL041C COG6 4
COD5 YGL005C COG7 2
DOR1 YML071C COG8 4
- YJR032W CPR7 1
MED9 YNR010W CSE2 1
- YLR087C CSF1 3
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